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ABSTRACT
Aquaculture is a multi-billion dollar industry worldwide. The United States is a
significant consumer to both fresh and marine aquaculture products. Aquaculture sales
in Rhode Island have dramatically increased in the last 20 years. In Rhode Island
nearly 4.3 million oysters were produced via aquaculture in 2012. Currently,
hatcheries and nurseries in the United States produce large amounts of a variety of
species of oysters, clams and scallops. Oysters are filter feeders and are exposed to
many microbes in the hatchery. Infectious diseases from bacterial pathogens in the
hatcheries can have serious impacts on production. Vibrio species are often
responsible for vibriosis disease outbreaks in bivalve larviculture hatcheries
worldwide. Another prevalent disease observed in oyster nurseries in the Northeastern
US is Juvenile Oyster Disease (JOD).
Probiotic agents are promising tools to reduce the risks of disease outbreaks in
aquaculture facilities. Two marine bacteria, Bacillus pumilus RI0695 and Phaeobacter
gallaeciensis S4, were previously reported to provide significant protection of the
Eastern oyster larvae Crassostreae virginica when challenged with the shellfish
pathogen Vibrio tubiashii. The goals of my dissertation research were to isolate and
identify the antibiotic(s) secreted by Phaeobacter gallaeciensis S4, to chemically
examine their mechanisms of action for probiotic activity, and to create probiotic
formulations of Bacillus pumilus RI0695 and of Phaeobacter gallaeciensis S4 for
delivery in shellfish larviculture facilities.
Chapter 2 describes the isolation and identification of the antibiotic tropodithietic
acid (TDA) from Phaeobacter gallaeciensis S4. Genes tdaA, tdaB, clpX and rpoE

were previously found to be necessary for the biosynthesis of TDA in Silicibacter sp.
TM104 (Geng, Bruhn et al. 2008, Karim, Zhao et al. 2013). Gene exoP is responsible
for the exopolysaccharide biosynthesis (Zhao 2014). Collaborative work suggests that
TDA contributes to the probiotic activity of P. gallaeciensis S4 but that antibiotic
production is not the sole mechanism of action. The basis for this finding was
biological and chemical analysis of S4 wild-type and genetic mutant strains producing
different levels of TDA (tdaA-, tdaB-, tdbD-, clpX, rpoE-, exoP-, and complement
strains rpoE-, exoP-) by high pressure liquid chromatography (HPLC) and ultra high
pressure liquid chromatography (UHPLC). HPLC analysis of culture extracts from the
tdaA-, tdaB- and tdbD- mutants confirmed loss of TDA production as compared to S4
wild type. Additional genetic mutant strains, clpX, rpoE-, exoP-, and complement
strains rpoE- and exoP- were created by insertional mutagenesis to further explore the
role of TDA and mechanisms regulating its production. UHPLC analysis of clpX
stationary phase culture extracts confirmed the lost production of TDA when
compared to a TDA standard. UHPLC analysis of complement strains clpX
demonstrated that TDA was present compared to a TDA standard. The exoP- mutant
produced TDA similar to the wild-type strain. Mutant strains that lack the production
of TDA had less protection of Eastern oyster larvae C. virginica to bacterial challenge
than the wild type or the genetic mutant strain that produced similar TDA
concentrations as the wild type. This research determined that TDA was necessary for
optimal probiotic activity.
Chapter 3 describes efforts to create a stable formulation of B. pumilus RI0695
for delivery at shellfish hatcheries. Currently there are no commercially available

probiotics for shellfish aquaculture. Granulation is robust, cost effective, and simple
proven method of formulation. A granular probiotic formulation of B. pumilus RI0695
was created by extruding dried B. pumilus RI0695 cells through three particle size
sieves (40s, 80s, and 325s). Three granule sizes of 420 µ, 177 µ and 43 µ were
successfully created. Granular (177 µ and 43 µ) formulations stored for 29 weeks and
22 weeks at room temperature (RT) were able to reduce mortality in C. virginica
larvae and seed, respectively, when challenged with V. tubiashii. This study suggests
the 43 µ granule formulation of B. pumilus RI0695 is a good candidate for commercial
use in shellfish hatcheries.
In Chapter 4, a study is presented showing an effort to create a lyophilized
probiotic formulation of P. gallaeciensis S4 that provides reduced mortality of C.
virginica larvae when exposed to the shellfish pathogen V. tubiashii RE22. Several
lyophilized formulations were prepared using varying amounts of two cryoprotectants
at two growth stage phases of the bacterium. The two best formulations used log phase
cells lyophilized with either 30% or and 40% mannitol as a cryoprotectant. The cell
viabilities of the two formulations were measured under various storage conditions (27
°C, 4 °C, 30 °C, and 30 °C with 75% humidity) over a 5-week period. S4 formulations
(30-M and 40-M) were tested at 1 week for probiotic protection of C. virginica seed
against V. tubiashii infection. Unfortunately, the lyophilization process and storage
significantly decreased the cell viability of both formulations (30-M and 40-M).
Further, there was no protection of the larvae when pre-exposed to either formulation.
Based on the in vivo results, a liquid P. gallaeciensis S4 formulation under starvation
conditions in NSS medium was prepared. The liquid formulation maintained a cell

viability of 108 CFU/mL over 8 weeks. Further research should be done to evaluate
these formulations in a hatchery study. More research must be done to refine the
formulation processes for commercial scale up.
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PREFACE
This dissertation was in accordance with the manuscript format guidelines
established by the Graduate School of the University of Rhode Island. The dissertation
includes an introduction and the following three manuscripts:
1. Literature review: Probiotics for disease management in commercial aquaculture
systems.
2. Isolation, Purification and Quantification of Tropodithietic Acid a Major
Contributor to the Probiotic Activity of Phaeobacter gallaeciensis S4 in Eastern
Oyster Crassostrea virginica
3. Preparation of a Granular Formulation of Bacillus pumilus RI0695 for Disease
Management in Eastern Oyster Crassostrea virginica hatcheries.
4.

Preparation of a Lyophilized Formulation of Phaeobacter gallaeciensis S4 for
Disease Management in Eastern Oyster Crassostrea virginica hatcheries.
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CHAPTER 1

LITERATURE REVIEW:
PROBIOTICS FOR DISEASE MANAGEMENT IN COMMERCIAL
AQUACULTURE SYSTEMS

1

Aquaculture value
Global aquaculture is a multi-billion dollar industry. Aquaculture is defined by
NOAA as the production of freshwater fish, marine fish, shellfish, and marine plants
(Elston, Hasegawa et al. 2008). In 2014, the Fisheries and Aquaculture Organization
(FAO) released an overview of major trends and issues which estimated aquaculture
production to be worth 137.7 billion USD worldwide (FAO 2014). The United States
is a significant contributor to both fresh and marine aquaculture sales, adding
approximately one billion dollars to the worldwide total (Elston, Hasegawa et al.
2008). Aquaculture sales in Rhode Island have dramatically increased from $83,518 in
1995 to $4.2 million in 2013 (Beutel 2013). In addition to this production boom, the
number of oyster farms in Rhode Island has grown from six to fifty-two (Beutel 2013).
In 2013, nearly 6.8 million oysters were produced via aquaculture in Rhode Island
(Beutel 2013).
Aquaculture production growth

The growth of worldwide aquaculture production revenue increased average
6.1 percent annually between 2001-2012 (FAO 2014). The total production of fish,
crustaceans, mollusks and other aquatic animals around the world increased
continuously to 158 million tonnes in 2010 (FAO 2014). In comparison, the capture
production has remained around 90 million tonnes over the last 15 years (FAO 2014).
Approximately 86% of seafood consumed by the U.S. is imported, around half of
which is produced via aquaculture (FAO 2014). According to The 2010 State of
World Fisheries and Aquaculture by the FAO, sixty-two percent of all farmed seafood
in the world is produced in China. An additional 26% of all farmed seafood is
2

produced in Asia outside of China. Europe and the Americas produced 4.5 percent
each of all farmed seafood (NOAA 2012).

United States Aquaculture Production
United States’ aquaculture industry, both freshwater and marine, supplies five
to seven percent of the national demand for seafood. Wild catch and aquaculture, both
imported and domestic, account for the sources of seafood production in the United
States. Many of the existing farms are located on territorial waters in Maine,
Washington, Hawaii RI and other states , and on land in ponds and tanks in several
states (NOAA 2012).

The U.S freshwater aquaculture industry produces primarily catfish, trout, and
tilapia. Two-thirds of U.S. marine aquaculture production is comprised of molluscan
shellfish such as oysters, clams, and mussels. The other third consists mainly of
shrimp, Atlantic salmon, steelhead trout, coho salmon, cod, sturgeon, red drum,
Pacific threadfin (moi), Hawaiian yellowtail, and cobia, with lesser amounts of
barramundi, seabass, seabream, and other species (NOAA 2012).

Diseases in aquaculture
Approximately 430 aquatic species have been domesticated for aquaculture
(Duarte, Marba et al. 2007). Rigorous culture of bivalve shellfish on a production
scale developed in the 1970’s. Currently, hatcheries and nurseries in the United States
produce large numbers of a variety of species of oysters, clams and scallops (Elston
1998). However, infectious diseases in the hatcheries have serious impacts on

3

production, with 45.5% of losses in aquaculture being due to diseases (Elston 1998,
FDA 2012).
Aquaculture hatchery operations are especially prone to bacterial diseases that
rapidly kill larvae. The hatchery environment has many factors that may impact the
growth and survival of cultured species. There are a combination of controllable and
chance factors that determine the composition of the resulting microﬂora in aquatic
animals (Vine, Leukes et al. 2006). The controllable factors include: salinity;
temperature; and feed quality (Vine, Leukes et al. 2006) . The gastrointestinal ﬂora of
aquatic animals reared in hatchery settings usually resemble the microﬂora initially
present in the rearing water, microalgae, and livefood (Gatesoupe 1999, Riquelme,
Jorquera et al. 2001, Vine, Leukes et al. 2006). Diseases in bivalve shellfish
hatcheries are caused by infectious organisms entering the hatchery from the same
three sources as other microbes: brood stock; seawater source; and algal food source
(Elston 1998). Once a pathogen has been introduced into the system, it can rapidly
cause disease and death in the aquatic animal. Major causative factors for
opportunistic infections in shellfish hatcheries are bacterial infections, which can enter
the system through the seawater source and/or the algal food source (Elston 1998).
Another source of opportunistic infections is viral. Viruses are generally transferred
from infected brood stock (Elston 1998). Aside from bacteria and viruses, other
pathogens include fungi and eukaryotic parasites.
Prevalent diseases observed in Eastern oysters (Crassostrea virginica) in the
Northeastern US and Atlantic Canada are multi-nucleated sphere X (MSX) disease,
dermo disease, juvenile oyster disease (JOD) and bonamiasis (shown in Table 1). A

4

major player in the development of infectious disease in Pacific oyster larvae
(Crassostrea gigas) hatcheries is Vibrio tubiashii.

5

Table 1. Diseases associated with the Eastern oyster Crassostrea virginica and the Pacific oyster Crassostrea gigas.

Disease
Multi-nucleated
Sphere X (MSX)
disease

Dermo Disease

6

Juvenile
(Roseovarious) Oyster
Disease

Bonamiasis

Pathogenic
Agent

Effects on Host

Occurrence of Disease

Decreased meat
quality, reduced
reproductive
capacity and
mortality

Observed from Maine to
Florida in the late
summer and early fall

Decreased growth,
typically between
60% and 80% after
two years of
exposure, and
mortality

Observed in Northeast
US and Atlantic Canada,
in increased temperatures
of seawater (>20 °C) and
salinity (> 15 parts per
trillion)

Roseovarious
crassostreae

Reduced growth of
juveniles along
with uneven shell
growth. Mortalities
of over 90% in
infected areas.

Observed in New York
and New England, in
mid- to late summer
when water temperature
is elevated (>25 °C)

Bonamia ostreae

Inability to close
shell completely.
Decimation of
infected hatchery.

Haplosporidium
nelson

Perkinsus
marinus

Washington State and
Maine, outbreaks occur
year round when
seawater temperatures
range from
12-20 °C.

Mechanism of
Virulence

Reference

Unknown

Elston 1990, Barber
1999

Infection through
ingestion, because it is
often observed in gut
tissue

Elston 1990, Barber
1999, Ford 2011

Unknown

Infects the host blood
cells, it can multiply
within blood cells and
spreads to all tissues

Gomez-Leon,
Villamil et al.
2008Romalde and
Barja 2010

Elston 1990, Barber
1999

Disease

Vibriosis

Vibriosis

Pathogenic Agent

Vibrio tubiashii

Vibrio
parahaemolyticus

7
Vibriosis

V. vulnificus

Effects on Host

Occurrence of Disease

Mechanism of action

Larvae exhibit
mantle and
feeding disruption,
and visceral
damage infection,
resulting in death
within 24 hours.
Infection have
been attributed to
59% decline in
production

Pacific oyster hatcheries,
when seawater
temperature is elevated
(>20 °C)

Two virulence factors
associated with
bacterium:
Metalloprotease and
hemolysin

Human
consumption of
infected oysters
can cause
gastroenteritis and
septicemia..

Abundant in marine
environments, when
seawater temperature is
elevated (>20 °C)

Clinical illness is
associated with
strains is hemolysin

DePaola, McLeroy et
al. 1997

Abundant in mollucs in
the Gulf coast.

Virulence factor
associated with
bacterium is
hemolysin

DePaola, McLeroy et
al. 1997

Distributed
throughout the
tissues of the
oyster.
Causative agent of
gastroenteritis
and septicemia
through human
consumption.

Reference

Decamp, Moriarty et
al. 2008, Elston 2008

MSX disease is caused by the eukaryotic parasite Haplosporidium nelsoni. H.
nelsoni cells usually appear first in gill tissue, indicating that the infective stage is
waterborne, which can only be confirmed by microscopic examination of oyster tissue
(Elston 1990, Barber 1999). Effects of the disease include decreased meat quality,
reduced reproductive capacity, and mortality (Elston 1990, Barber 1999). These
outbreaks mainly occur in the late summer and fall and have been observed from
Maine to Florida (Elston 1990, Barber 1999). The mode of transmission of this
pathogen is unknown.
Dermo disease of Eastern oysters, C. virginica, is caused by a highly infectious
eukaryotic parasite Perkinsus marinus. The presence of P. marinus is determined by
microscopic examination of oyster gut tissue cultured in thioglycollate medium
(Elston 1990, Barber 1999, Ford 2011). It has been reported that the primary route of
infection is through ingestion, because it is often observed in gut tissue (Elston 1990,
Barber 1999, Ford 2011). The primary effect of Dermo disease is a decrease in
growth, typically between 60% and 80% after two years of exposure (Ford 2011). The
disease can be directly passed from infected to uninfected oysters. It has been reported
that P. marinus causes the greatest mortality at temperatures greater than 20 °C and at
a salinity above 15 parts per trillion (ppt) (Ford 2011).
Roseovarious crassostreae is another bacterium that causes serious infections
in juvenile oysters. This pathogen, the causative agent of Juvenile or Roseovarious
Oyster Disease (JOD), is endemic to New York and the New England area (NOAA
2009, Romalde and Barja 2010). JOD has been responsible for population mortalities
of over 90% in highly impacted areas. Outbreaks of R. crassostreae may be associated
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with elevated water temperature (>25 °C) (Gomez-Leon, Villamil et al. 2008, NOAA
2009) (NOAA 2009, Romalde and Barja 2010). Indications of the disease are reduced
growth of the oyster along with uneven shell growth. The disease is characterized by
the presence of conchiolin deposits, or the presence of brown rings, on the inner shell
surfaces. JOD follows a seasonal pattern, with most mortality occurring in mid- to
late-summer, coinciding with warm water temperatures. The disease can be
transmitted from oyster to oyster, but the toxins and virulence factors are still
unknown for this pathogen (Romalde and Barja 2010).
Bonamiasis, a disease that originated in the European oyster Ostrea edulis, is
caused by the eukaryotic parasite Bonamia ostreae (Elston 1990, Barber 1999). It has
been reported to occur in Washington State and in Maine (Elston 1990, Barber 1999).
B. ostreae has been reported to multiply within blood cells and spreads to all tissues,
interfering with physiological processes (Elston 1990, Barber 1999). A sign of early
stage bonamiasis is the inability of the shell to close completely (Elston 1990, Barber
1999). Diagnosis of B. ostreae requires microscopic examination of oyster blood or
tissue (Elston 1990, Barber 1999). Outbreaks of bonamiasis can be devastating to a
hatchery as it is highly infectious and is transmitted directly from oyster to oyster. It
has been reported that mortality can approach 100% (Elston 1990, Barber 1999).
These outbreaks can occur year round, with ideal temperature conditions for infections
ranging from 12 °C to 20 °C. B. ostreae is reportedly found consistently in Maine with
a low prevalence in some populations of O. edulis (Elston 1990, Barber 1999).

A variety of Vibrio species are often responsible for disease outbreaks in
bivalve larviculture hatcheries, including Vibrio coralliilyticus which has previously
9

been mistaken for V. tubiashii RE22 which cause bacillary necrosis in oyster larvae.
Vibriosis outbreaks in larvae are characterized by mantle and feeding disruption, loss
of motility, and visceral damage usually resulting in larval death within 24 hours
(Porsby, Nielsen et al. 2008). This disease is particularly problematic in hatcheries that
culture bivalves (Decamp, Moriarty et al. 2008, NOAA 2009, Romalde and Barja
2010). From 2006 to 2007, increased water temperature, and bad water quality maybe
the causative factors for several outbreaks of V. tubiashii in shellfish hatcheries and
nurseries in North America (Elston, Hasegawa et al. 2008). These pathogenic
outbreaks caused a 59% decline in oyster larvae production , thus affecting the overall
production of cultured oysters for human consumption. In addition, although they
don’t affect the shellfish hosts, V. parahaemolyticus and V. vulnificus have been
linked to foodborne illnesses in humans such as gasterenteritis or in severe cases
septicemia through consumption of raw oysters (DePaola, McLeroy et al. 1997, CDC
2015). Both bacterial species are prevalent in seawater with elevated temperatures
(>20 °C) (DePaola, McLeroy et al. 1997, CDC 2015).

Studies by Hasegawa and coworkers determined two potential virulence
factors in Vibrio tubiashii, metalloprotease and hemolysin, which they termed
“extracellular products” (Hasegawa, Lind et al. 2008, Porsby, Nielsen et al. 2008).
Both extracellular products are regulated by quorum sensing (Hasegawa, Lind et al.
2008). Similar to Vibrio anguillarum, at high cell density in V. tubiashii the
metalloprotease gene is expressed while the hemolysin gene is down regulated (Li,
Rock et al. 2008). Toxicity in oyster larvae was diminished when V. tubiashii
supernatants were treated with metalloprotease inhibitors. It was reported that
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inhibition of hemolysin also caused a decrease in larval toxicity (Hasegawa, Lind et al.
2008). The study identified the structural genes encoding for metalloprotease (vtpA)
and hemolysin (vthA) for V. tubiashii (Hasegawa, Lind et al. 2008). The vtpA gene
encoded for a zinc metalloprotease, and had a high sequence similarity to genes found
in other Vibrio species (Hasegawa, Lind et al. 2008). It is still unknown how vtpA
contributes the bacillary necrosis. However, it has been suggested that vtpA
contributes to the degradation of oyster larvae tissues. The vthA gene from V.
tubiashii has significant homology with the vvhA gene found in V. vulnificus
(Hasegawa, Lind et al. 2008). The virulence factor associated with the gastroenteritis
in V. parahaemolyticus is thermostable direct hymolysin (TDH). It has been studied
that both trh and tdh are significant in the virulence of V. parahaemolyticus (Shirai, Ito
et al. 1990).
Disease Management in Bivalve Aquaculture Facilities

In the last two decades there has been an increased incidence of disease
outbreaks due to bacterial pathogens in shellfish hatcheries (Boettcher, Geaghan et al.
2005, Gomez-Leon, Villamil et al. 2008, USDA 2008, NOAA 2009). In particular,
pathogen outbreaks of Vibrio spp. can have devastating effects on oyster production in
shellfish hatcheries (Romalde and Barja 2010). Vibrio pathogenic outbreaks can cause
a 59% decline in oyster larvae production (Balcazar, de Blas et al. 2006).

The treatment of pathogenic disease in aquaculture is problematic due to
limited resources and treatment options (Decamp, Moriarty et al. 2008).
Aquaculturists have explored using filtration systems, ozonolysis, UV and electrolytic
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treatments of seawater, adjusting salinity, and selective breeding (Boettcher, Barber et
al. 1999, Ford and Borrero 2001, Jorquera, Valencia et al. 2002, Wijesekara, Nomura
et al. 2006, Park, Kim et al. 2011, FAO 2014). Additionally, investigations into the
use of probiotics as a new disease management tool are being explored (Westerdahl,
Olsson et al. 1991, Elston 1998, Rengpipat, Phianphak et al. 1998, Verschuere,
Rombaut et al. 2000, Spanggaard, Huber et al. 2001, Farzanfar 2006, Vine, Leukes et
al. 2006, Decamp, Moriarty et al. 2008, Kesarcodi-Watson, Kaspar et al. 2008).
Vaccines are not feasible in bivalves because they lack an antibiody immune response
(Gomez-Chiarri 1999). The use of antibiotics in aquaculture can have potentially
detrimental effects for increasing the development of drug-resistant bacteria involved
in human and other animal diseases (Vaseeharan and Ramasamy 2003, Farzanfar
2006).

Disease reduction strategies can be matched to the pathogens of interest.
Management of MSX disease is aided by the fact that H. nelsoni cannot tolerate
salinity below 10 ppt and only causes severe mortality above 20 ppt. Sites that
regularly experience salinity below 20 ppt are be less impacted by MSX than other
areas. H. nelsoni can be eliminated from oysters by moving them into an environment
of a salinity of 10 ppt or less. Research has also shown that MSX mortality can be
reduced through selective breeding (Burreson and Ford 2004). Ford and Borrero
(2001) reported that filtration of the seawater entering the hatchery with a 1µm filter
cartridge and followed by exposure to UV irradiation (30,000 µWs-1cm-2) prevented
infection by both eukaryotic parasites H. nelsoni, the causative agent for MSX disease,
and P. marinus, the causative agent for Dermo disease (Ford and Borrero 2001).
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Filtered sterilized seawater also yielded good results in preventing (82%) JOD in the
eastern oyster C. virginica (Boettcher, Barber et al. 1999).
Ozonation in freshwater recirculating hatchery systems has been widely used
for almost 30 years to form oxidized organic matter to control bacterial diseases.
There have been some conflicting reports that ozonation in seawater can have toxic
effects due to a reaction with bromine. Ozonation by-products are known to oxidize
organic material forming total oxidized residual compounds (TRO). A TRO
concentration of 0.06-0.1 mg/L is needed to inactivate microorganisms. Ozonation in
seawater recirculation systems for black seabream, Acanthopargus schlegelii, fed at
20g O3/kg feed day-1 significantly reduced heterotrophic bacteria in the inlet water
measured after six consecutive days of treatment (Park, Kim et al. 2011). Electrolytic
methods have been successful in reducing microalgae, bacteria, and viruses (Jorquera,
Valencia et al. 2002, Wijesekara, Nomura et al. 2006, FAO 2014). This process uses a
nonmembrane electrolytic cell to dissociate sodium chloride molecules in seawater to
form hypochloride ion and sodium ion. (Jorquera, Valencia et al. 2002). A study using
electrolytically treated seawater in aquaculture systems reported that an electrolytic
current intensity of 1.3 A was able to reduce V. anguillarum to undetectable
concentrations and produced minimal free chloride ions (Jorquera, Valencia et al.
2002). Electrolysis of seawater at 4.0 A followed by neutralization with sodium
thiosulfate was able to stimulate the growth of cultured Isochrysis galbana as
compared to both the control (sterilized seawater) and UV treatments of seawater
(Jorquera, Valencia et al. 2002).
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The methods for treating the hatchery water supply, including treatments with
ozone, filtration, heat, UV irradiation, and electrolysis (Jorquera, Valencia et al. 2002),
are effective for minimizing pathogenic diseases. However, they can have a high cost
due to the need for expensive equipment and high energy input (Park, Kim et al.
2011). Thus, they lack practicality for many hatchery facilities.
Probiotics have shown promise as a disease management tool for aquaculture
(Kesarcodi-Watson, Kaspar et al. 2008). Unlike chemical antibiotics, probiotics are
provided to larvae prior to infection outbreaks in order to control pathogens in the
hatchery. They are defined by the World Health Organization as “live microbes which
have a beneficial effect on the host” (Liang 2003). They are a “green” alternative to
the use of antibiotics since they are unlikely to contribute to the rising problem of
antimicrobial resistance (Verschuere, Rombaut et al. 2000).
Probiotics in shellfish aquaculture
A full definition of a marine probiotic suggested by Vershuere et al. (2000) is:
A live microbial adjunct which has a beneficial effect on the host by modifying the
host-associated or ambient microbial community, by ensuring improved use of the
feed or enhancing its nutritional value, by enhancing the host response towards
disease, or by improving the quality of its ambient environment including water
quality and interaction with phytoplankton (Verschuere, Rombaut et al. 2000).
More widely stated, “a probiotic is an entire or component(s) of a microorganism that
is beneficial to the health of the host” (Salminen, von Wright et al. 1998, Irianto and
Austin 2002). Additionally, immunostimulants or bacterial by-products, such as
peptidoglycan and lipopolysaccharides that have been shown to promote an enhanced
immune response from the host can be considered to be prebiotics (Itami, Asano et al.
1998, Smith, Brown et al. 2003, Kesarcodi-Watson, Kaspar et al. 2008).
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Investigations of probiotics in aquaculture have been aimed at improving
survival rate and/or growth of various aquacultured animals (Table 1). Probiotics that
are chosen for aquaculture must be able to proliferate in an aquatic environment and
there must be a consideration of the relationship of the aquatic animal and its external
environment. Potential pathogens have the ability to proliferate in the seawater that
may enter the hatcheries (Hansen and Olafsen 1999, Verschuere, Rombaut et al. 2000,
Kesarcodi-Watson, Kaspar et al. 2008).
Marine probiotics have several proposed modes of action, including the
production of antimicrobial compounds, competition for adhesion sites and nutrients,
stimulation of the host immune system, and providing enhanced nutrition to the host
(Queiroz and Boyd 1998, Murthy and TJ 1999, Ziaei-Nejad, Rezaei et al. 2006, Cude,
Mooney et al. 2012). The most common examined mechanism of action in probiotic
candidate bacteria has been investigating the production of inhibitory substances. Such
studies seek to identify bacteria that secrete molecule(s) that limit the growth of
pathogens in vitro as candidate probiotics that then are tested in vivo (Westerdahl,
Olsson et al. 1991, Sugita, Shibuya et al. 1996, Bly, Quiniou et al. 1997, Sugita,
Matsuo et al. 1997, Spanggaard, Huber et al. 2001, Chythanya, Karunasagar et al.
2002, Sugita, Okano et al. 2002, Hjelm, Riaza et al. 2004).
There are four methods that are commonly employed to screen for growth
inhibitory substances in vitro: the double layer method, the well diffusion method, the
cross-streak method, and the disc diffusion method. All methods are based on the
principle that a bacterium (the producer) secretes an extracellular substance which is
inhibitory to itself or another bacterial strain (the indicator). The inhibitory activity is
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displayed by growth inhibition of the indicator in agar medium. In some cases, initial
in vitro screening was followed by small scale testing of short-listed candidates in vivo
for either pathogenicity to the host (Makridis, Jon Fjellheim et al. 2000, Chythanya,
Karunasagar et al. 2002, Hjelm, Riaza et al. 2004) or host protection when challenged
with a pathogen (Rengpipat, Phianphak et al. 1998, Gram, Melchiorsen et al. 1999,
Robertson, O'Dowd et al. 2000, Irianto and Austin 2002, Vaseeharan and Ramasamy
2003, Lategan, Torpy et al. 2004, Lategan, Torpy et al. 2004). For example, Irianto et
al. (2002) demonstrated that several candidate probiotics identified as Aeromonas
hydrophila A3-51, V. fluvialis, Carnobacterium sp. displayed antagonistic properties
towards the pathogen Aeromonas salmonicida (Irianto and Austin 2002). Many
investigations have observed a positive protective effect in in vivo studies following
positive antagonism assays in vitro (see Table 2) (Gibson, Woodworth et al. 1998,
Rengpipat, Phianphak et al. 1998, Makridis, Jon Fjellheim et al. 2000, Robertson,
O'Dowd et al. 2000, Chythanya, Karunasagar et al. 2002, Irianto and Austin 2002,
Vaseeharan and Ramasamy 2003, Hjelm, Riaza et al. 2004, Lategan, Torpy et al.
2004, Lategan, Torpy et al. 2004).
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Table 2. Some examples of promising probiotics in shellfish larviculture and their effect on the host.
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Microbe

Host Species

Effect on Host

Reference

Arthrobacter sp. strain 77

Argopecten purpuratus

Production of inhibitory compounds;
Probiotic replaced resident microflora
within 24 hours.

Riquelme et al. (2000)

Vibrio sp. strains 11 and C33

Argopecten purpuratus

Colonize the digestive tract when
administered with microalgae

Avendano & Riquelme
(1999)

Vibrio sp. C33, Pseudomonas
sp. 11 and Bacillus sp. strain
B2

Argopecten purpuratus

Increased the number of larvae when
compared to antibiotic treatment

Riquelme et al. (2001)

Aeromonas media strain
A199
Aeromonas media strain
A199

Bacillus S11

Crassostrea gigas
Anguilla australis
Richardson

Penaeus monodon PL-10

Increased survival rate when
challenged with V. tubiashii;
Production of inhibitory substance
inhibiting growth of Saprolegnia sp.
Post larvae survival was increased
when challenged with V. harveyi;
Probiont provided cellular and
humoral immune defense responses

Gibson et al. (1998)
Lategan et al. (2003)

Rengpipat et al. (2000)

Microbe

Host Species

Effect on Host

Reference

Scophthalmus maximus L. gut
strains 4:44 PB52

Brachionus plicatilis

Makridis et al. (2000)

Bacillus S11

Penaeus monodon

Colonization of the gut of larvae
Improvement in survival when
coupled with ozonation treatments

Lactobacillus sporogenes

Macrobrachium
rosebergii

Improved growth rate and feed
efficiency of post larvae when fed as a
bio-encapsulated probiotic.

Venkat et al. (2004)

Bifidobacterium
thermophilum

Penaeus japonicus

Improved survival by peptidoglycan
against Vibrio penaecida

Itami et al. (2002)
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Bacillus subtilis BT23

Penaeus sp.

Bacillus spp.

Fenneropenaus
indicus

Pseudomonas strain I-2

Penaeus monodon

Reduced mortality by 90% when
challenged with V. harveyi.
Increase in survival and wet weight,
increases in specific activities of
amylase, total protease
Production of inhibitory compounds
against V. harveyi, V. fluvailis, Vibrio
parahaemolyticus, Vibrio damsela
and Vibrio vulnificus

Meunpol et al. (2003)

Vaseeharan et al. (2003)

Ziaei-Nejad (2006)

Chythanya et al. (2002)

Microbe

Pseudomonas sp. PM11 and
Vibrio fluvalis sp.

Vibrio P62, and Bacillus P64

Carnobacterium sp.
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Bacillus sp. RI0695

Host Species

Effect on Host

Reference

Penaeus monodon

Increased survival of P. monodon
because of its antagonistic effect
towards V. harveyi

Meunpol et al. (2003)
Vaseeharan et al. (2003)

Penaeus vannamei

Salmo salar L. and
Oncorhynchus mykiss

Crassostrea virginica

Crassostrea virginica

Gullian et al. (2004)

Reduction of disease by A.
salmonicida in Oncorhynchus mykiss,
V. ordalii in Salmo salar L., and
Yersinia ruckeri in Salmo salar L. and
Oncorhynchus mykiss
Increased survival of larvae when
challenged with Vibrio tubiashii,
through production of inhibitory
compounds and colonization.
Demonstrated against two
phytoplankton, Skeletonema costatum
and Heterosigma akashiwo

Claulobacter sp. PK654

Phaeobacter gallaeciensis S4

Both showed inhibitory effects against
Vibrio harveyi. However P64 showed
immunostimulatory features as well

Increased survival of larvae when
challenged with Vibrio tubiashii.
Through inhibitory compounds,
colonization and biofilm formation.

Karim et al. (2013)

Kawano, Asada et al.
1998

Karim et al. (2013)

Various microorganisms produce antimicrobial compounds that limit the
growth of aquaculture pathogens. While not a probiotic organism, Skeletonema
costatum, a common phytoplankton used in larviculture of mollusks and crustaceans,
produces an organic extract capable of inhibiting the growth of V. anguillarum and
three Vibrio species (Kesarcodi-Watson, Kaspar et al. 2008). Additionally, the
antibiotic thiotropocin produced by Claulobacter sp. PK654 demonstrated inhibitory
activity towards the fish pathogen Lactococcus garvieae, but also had activity against
two phytoplankton, Skeletonema costatum and Heterosigma akashiwo (Kawano,
Asada et al. 1998, Naviner, Bergé et al. 1999, Kesarcodi-Watson, Kaspar et al. 2008).
A study by Meunpol et al. (2003) suggested that the probiotic Bacillus S11 was a
contributing factor to the survival of black tiger shrimp (Penaeus monodon) in the
presence of the bacterial pathogen V. harveyi (Meunpol, Lopinyosiri et al. 2003).
Certain Bacillus sp. have been shown to antagonize the growth of pathogenic Vibrio
spp. (Vaseeharan and Ramasamy 2003), thus suggesting a possible mechanism of
action for Bacillus S11.
There are two major restrictions to the approach of only screening for the
production of antimicrobial substances by potential probiotic microbes (KesarcodiWatson, Kaspar et al. 2008). One is that other modes of probiotic activity, such as
immunostimulation, digestive enzymes production, competition for attachment sites,
and nutrient enhancement, are not revealed by these types of experiments. These could
be major contributing mechanisms of action and would be otherwise overlooked.
Another drawback is that positive results in vitro may not translate into the anticipated
in vivo effects (Kesarcodi-Watson, Kaspar et al. 2008). For example, P. fluorescens
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strain AH2 demonstrated inhibitory effects against the salmon pathogen A.
salmonicida in vitro, but no protective effect was found when the probiotic was tested
in vivo (Gram, Melchiorsen et al. 1999, Gram, Løvold et al. 2001). The same result
was seen by Ruiz-Ponte et al. (1999), when in vitro antagonism of a putative probiotic
bacterium did not translate to protection of scallop larvae once challenged by a
pathogen. Similarly, a bacterium that is not inhibitory in the laboratory might actually
be antagonistic in vivo (Ruiz-Ponte, Samain et al. 1999). This suggests other traits that
might be required, such as successful colonization of the host by the putative probiotic
organism. In other studies, probiotics have been tested further for properties such as
bile resistance (Chabrillón, Arijo et al. 2006), attachment capacity (Olsson,
Westerdahl et al. 1992, Hjelm, Riaza et al. 2004), immunostimulation (Rengpipat,
Phianphak et al. 1998, Irianto and Austin 2002, Gullian, Thompson et al. 2004),
competition for adhesion sites (Vine, Leukes et al. 2004, Chabrillón, Arijo et al. 2006)
and competition for nutrients (siderophore production) (Gram, Melchiorsen et al.
1999). In practice, these latter studies test whether or not a probiotic that produces
diffusible inhibitory substances also possesses other modes of probiotic action.
Although competition for adhesion sites has been widely suggested as a mode of
action, this has been demonstrated only in vitro. There are studies reporting an
adhesion of certain bacteria to intestinal mucus in vitro (Krovacek, Faris et al. 1987,
Olsson, Westerdahl et al. 1992, Garcia, Otto et al. 1997, Jöborn, Olsson et al. 1997,
Hansen and Olafsen 1999, Gullian, Thompson et al. 2004, Vine, Leukes et al. 2004).
The attachment properties of potential probiotics measured in vitro cannot be
presumed to exert the same effect in vivo (Vine, Leukes et al. 2004). This study
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examined the competitive exclusion effect of five probiotics isolated from the gut of
the common clownfish, Amphirion percula, versus the pathogens A. hydrophila and V.
alginolyticus on fish intestinal mucus. Only one of the probiotic strains inhibited the
attachment of one of the pathogens on the intestinal mucus of A. percula (Vine,
Leukes et al. 2004).

Another probiotic mechanism of action is the ability to outcompete a pathogen
for attachment sites. Probiotics that use this particular mechanism of action would
have a distinct advantage if the addition of probiotic bacterium was introduced during
the initial egg fertilization steps of larviculture (Irianto and Austin 2002). Several
studies have suggested that a probiotic effect may be seen due to competition for
energy sources with pathogenic bacteria (Rico-Mora, Voltolina et al. 1998,
Verschuere, Rombaut et al. 1999, Verschuere, Rombaut et al. 2000). Enhanced growth
and survival were observed in Artemia sp. pre-exposed to nine strains (LVS1–LVS9) of
bacteria before challenge with V. proteolyticus. The protective effect was attributed to
the competition for energy sources and for adhesion sites between the probiotic
bacteria and pathogen V. proteolyticus (Verschuere, Rombaut et al. 1999).
Competition for iron has been reported as an important factor in marine
bacterial systems. Iron is necessary for the growth of most bacteria. However, the
ferric Fe3+ form is found in limited amounts in the tissues and body fluids of the host
animals (Verschuere, Rombaut et al. 2000). Both probiotic and pathogenic bacteria
may produce siderophores that bind iron, increasing microbial growth (Gram,
Melchiorsen et al. 1999). It has been hypothesized that probiotics producing
siderophores could compete with potential pathogens for iron (Kesarcodi-Watson,
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Kaspar et al. 2008, Watson-Kesarcodi 2008). This may deprive pathogens of iron and
limit their propagation (Gram, Melchiorsen et al. 1999, Kesarcodi-Watson, Kaspar et
al. 2008). This was observed by Gram et al. (1999) who found that a culture
supernatant of P. fluorescens inhibited the growth of V. anguillarum when incubated
in low iron conditions (Gram, Melchiorsen et al. 1999, Kesarcodi-Watson, Kaspar et
al. 2008). A similar result was observed in vivo. Constant exposure of P. fluorescens
either in feed or in the water reduced mortality in Calta calta when challenged with
pathogenic Vibrio (Mohideen, Mohanb et al. 2010).
Another mode of action that probiotics may provide protection to the host is an
immunostimulant effect (Kesarcodi-Watson, Kaspar et al. 2008). Itami et al. (1998)
found increased phagocytic activity of shrimp granulocytes compared to controls of
Marsupenaeus japonicas, the Japanese tiger prawn, when treated with the
peptidoglycan of Bifidobacterium thermophilum and then challenged with V.
penaeicida (Itami, Asano et al. 1998). A study by Gullian et al. (2004) tested the
immunostimulation of healthy wild shrimp by a live Vibrio sp. (P62 and P63) and
Bacillus sp. (P64) using the pathogen V. alginolyticus (IIi) as a positive control
(Gullian, Thompson et al. 2004). They concluded that Bacillus sp. P64 showed both
probiotic and immunostimulatory effects (Gullian, Thompson et al. 2004, KesarcodiWatson, Kaspar et al. 2008).
There are many probiotic strains of Bacillus bacteria cited as useful for the
treatment of bacterial disease in aquaculture (Rengpipat, Phianphak et al. 1998,
Gatesoupe 1999, Murthy and TJ 1999, Riquelme, Jorquera et al. 2001, Meunpol,
Lopinyosiri et al. 2003, Farzanfar 2006, Vine, Leukes et al. 2006, Ziaei-Nejad, Rezaei
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et al. 2006, Decamp, Moriarty et al. 2008, Romalde and Barja 2010). In particular,
Bacillus spp. have shown promise in crustacean and mollusk aquaculture (Queiroz and
Boyd 1998). Several species of Bacillus have been used to increase the survival of
crustaceans (Queiroz and Boyd 1998, Rengpipat, Phianphak et al. 1998, Meunpol,
Lopinyosiri et al. 2003, Vaseeharan and Ramasamy 2003, Cude, Mooney et al. 2012).
These probiotic candidates were initially screened in vitro for inhibitory substances
and many were further tested in vivo for their probiotic activity. For example, a study
by Rengpipat et al. examined the growth of P. monodon and its resistance to Vibrio
when fed with Bacillus (BS11) (Rengpipat, Phianphak et al. 1998). Their results
suggested that the growth and survival rates of P. monodon were signiﬁcantly higher
than the controls due to probiotic stimulation of cellular and humoral immunity
(Rengpipat, Phianphak et al. 1998).
Bacteria belonging to the genus Phaeobacter have also shown promise as
probiotic agents for aquaculture. Phaeobacter are α-proteobacteria belonging to the
Roseobacter clade, which comprises the majority of oceanic bacterioplankton
(Brinkhoff, Bach et al. 2004, Bruhn, Nielsen et al. 2005, Porsby, Nielsen et al. 2008,
Porsby, Webber et al. 2011). Previous studies have reported several Roseobacter
isolates that exhibit antagonistic effects against pathogenic Vibrio species that are
problematic in cod and turbot larviculture (Brinkhoff, Bach et al. 2004, Porsby,
Nielsen et al. 2008, Porsby, Webber et al. 2011). Roseobacter clade isolates have
been shown to produce tropodithetic acid (TDA), an antibiotic with potent effects
against marine and human pathogens.
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The structure of TDA was reported by Liang to be a tropolone fused to a four
membered ring incorporating a disulfide (Brinkhoff, Bach et al. 2004, Bruhn, Nielsen
et al. 2005, Porsby, Webber et al. 2011, D'Alvise, Lillebo et al. 2012). TDA has been
proposed to be a tautomer of thiotropocin, another broad-spectrum antibiotic (Bentley
2008, Greer, Aebisher et al. 2008, Porsby, Webber et al. 2011, Seyedsayamdost, Carr
et al. 2011). The structure of thiotropocin is a tropolone attached to a five membered
thiolactone ring (Figure 1), and was supported by 13C labeling studies by Cane and
coworkers (Cane, Wu et al. 1992). Tropodithietic acid (TDA) was first described by
Liang from bacteria belonging to the Roseobacter clade (Liang 2003). The structure
elucidation data included mass spectrometry,UV, 1H, 13C, HSQC, HMBC NMR, IR,
and X-ray data. Many papers that work with Roseobacter clade bacteria attribute the
antibiotic activity to TDA and subsequently cite this dissertation (Brinkhoff, Bach et
al. 2004, Bruhn, Nielsen et al. 2005, Porsby, Nielsen et al. 2008, Porsby, Webber et al.
2011, Seyedsayamdost, Carr et al. 2011). Thiotropocin had broad spectrum antibiotic
activity against human pathogens was previously isolated from Pseudomonas
(Kintaka, Ono et al. 1984). In 2006 Laatsch cited that the unpublished data suggesting
the structural assignments of TDA were incorrect (Laatsch 2006). Computational
studies carried out by Greer et al. provided insight that tropodithietic acid and
thiotropocin exist as isomers rather than a single structure with a symmetric hydrogen
bond (Greer, Aebisher et al. 2008).
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Figure 1. Antibiotic produced by certain bacteria belonging to the genera Phaeobacter,
Ruegeria, and Roseobacter that exhibit probiotic activity against V. anguillarum.

Several in vivo studies have shown promise toward the development of
probiotic agents in shellfish, particularly in crustaceans. For example, Lactobacillus
sp. was examined for activity against gram negative bacteria in freshwater prawns
(Venkat, Sahu et al. 2004). Bifidobacterium thermophilum derived peptidoglycan
proved to be successful in vivo against V. penaeicida in shrimp (Itami, Asano et al.
1998). Several Bacillus sp. are active against V. harveyi in shrimp aquaculture
(Vaseeharan and Ramasamy 2003) (Moriarty 1998, Meunpol, Lopinyosiri et al. 2003,
Gullian, Thompson et al. 2004). Alavandi et al. (2004) examined two candidate
probiotics, Pseudomonas sp. PM11 and Vibrio fluvalis sp. PM 17, for their ability to
cause immunostimulation in shrimp (Alavandi, Vijayan et al. 2004). Gibson et al.
demonstrated that probiotic candidate Aeromonas media sp. 199 produced an
inhibitory substance that contributed to the antagonistic effects in vitro as well in vivo
(Gibson, Woodworth et al. 1998). Aeromonas media sp. 199 increased the survival
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rate of 2-6 day old Pacific oyster larvae Crassostrea gigas over five days in a V.
tubiashii challenge (Gibson, Woodworth et al. 1998). Karim et al. (2013) determined
both Bacillus pumilus RI0695 and Phaeobacter gallaeciensis S4 exhibited
antagonistic effects towards V. tubiashii in vitro (Karim, Zhao et al. 2013).
Additionally the probionts were able to protect Crassostrea virginica larvae when
challenged with V. tubiashii in vivo (Karim, Zhao et al. 2013). Karim et al. (2012)
postulated that the potential mechanisms of action for B. pumilus RI0695 and P.
gallaeciensis S4 could be the excretion of an antibiotic molecule, biofilm formation by
the bacterium, immune modulation of the oyster larvae, and colonization of marine
surfaces (Karim, Zhao et al. 2013).
Use of probiotics in bivalve shellfish hatcheries
Understanding the potential mechanisms of action of probiotics would be
useful for determining the optimal modes of delivery in order to achieve disease
management in commercial settings. It is necessary to ensure that probiotic microbes
are non-toxic to both the intended host and the microalgal feed. Microalgae are
generally used as a food source in larviculture and probiotic epiphytes could promote
phytoplankton growth (Haines and Guillard 1974, Ukeles and Bishop 1975, Fukami,
Nishijima et al. 1992, Fukami, Nishijima et al. 1997, Kesarcodi-Watson, Kaspar et al.
2008). Probionts that attach to microalgae may also be delivered to larvae as algal
epiphytes. Gomez-Gil et al. (2002) co-cultured shrimp probiotic, V. alginolyticus
strain C7b, with Chaetoceros muelleri, a feed for shrimp larvae, without having any
adverse effect on the microalgae (Gomez-Gil, Roque et al. 2002). Avendaño and
Riquelme (1999) investigated the growth of seven bacterial strains co-cultured with
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Isochrysis galbana (Avendaño and Riquelme 1999). The co-culture of bacterium
Vibrio sp. C33 significantly enhanced the ingestion of the candidate probiotic
bacterium in larval scallop, Argopecten purpuratus (Avendaño and Riquelme 1999).
Bairagi et al. (2004) examined the benefit of adding two probiotic candidates, B.
subtilis and B. circulans, derived from adult carp Cyprinus carpio, to the diet of Labeo
rohita (rohu) (Bairagi, Sarkar Ghosh et al. 2004). They found that the addition of both
Bacillus bacteria increased rohu’s growth, feed conversion ratio, and protein
efficiency ratio (Bairagi, Sarkar Ghosh et al. 2004). It was hypothesized that this
increase was due to the extracellular cellulolytic and amylolytic enzyme production by
the bacteria (Bairagi, Sarkar Ghosh et al. 2004, Kesarcodi-Watson, Kaspar et al.
2008).
Commercially available probiotics for shellfish aquaculture
Although a number of potential probiotics have been studied in shellfish
aquaculture, no commercial products are currently available. This is despite the fact
that probiotic agents have been developed for other aquacultured species, including
penaeid shrimps, catfish, rotifers, and tilapia (Hirata, Murata et al. 1998, Queiroz and
Boyd 1998, Murthy and TJ 1999, Irianto and Austin 2002, Cutting 2011,
Parthasarathy, Ramasubramanian et al. 2012). All of these commercial probiotics are
derived from gram-positive bacteria, such as Bacillus spp.
It has been suggested that various gram positive and gram negative marine
bacteria are possible candidate probiotics for commercial hatchery settings. However,
more research, including the evaluation and development of various probiotic
formulation techniques, must be performed in order to overcome the challenges of
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creating a product that meets the criteria of a dry, stable, and viable formulation over
time while inducing a safe and protective probiotic effect.
Conclusion
Aquaculture production is estimated to be worth 130.2 billion USD worldwide
according to FAO overview of major trends and issues (FAO 2014) . Hatcheries and
nurseries in the United States produce large numbers of a variety of species of oysters,
clams and scallops (Elston 1998). These hatcheries can be infected with bacterial
diseases and such infection can have serious impacts on production, with 45.5% of
losses in hatchery aquaculture attributed to infectious diseases (FDA 2012). Losses in
production due to disease may thus result in tremendous economic loss. Aquaculturists
have explored using filtration systems, electrolytic, ozonolysis and UV treatments of
seawater, adjusting salinity, and selective breeding as disease management tools.
Vaccines are not feasible in bivalves. The use of antibiotics in aquaculture can have
potentially detrimental effects, including the development of antibiotic-resistant
organisms, including the development of drug- resistant bacteria that are causative
factors for human and animal diseases (Vaseeharan and Ramasamy 2003, Farzanfar
2006). Additionally, investigations into the use of probiotics as new disease
management tools are being conducted.

Karim et al. (2013) demonstrated that probiotic candidates Bacillus pumilus
RI0695 and Phaeobacter gallaeciensis S4 were antagonistic against growth of V.
tubiashii in vitro and were able to protect C. virginica larvae when challenged with V.
tubiashii in vivo. Chapter Two presents a chemical investigation into the mechanism
of action of candidate probiotic P. gallaeciensis S4. Although there has been much
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promise in the study of potential probiotics in shellfish aquaculture, no commercial
products are currently available, a situation which affords ample opportunities for the
investigation and development of probiotics for this application. Chapters Three and
Four summarize experiments based upon classic pharmaceutical techniques, including
granulation and lyophilization, in order to formulate two promising probiotic bacteria,
B. pumilus RI0695 and P. gallaeciensis S4, respectively, for eventual use in
commercial aquaculture operations.
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Abstract
Previous studies have shown that the marine bacterium Phaeobacter
gallaeciensis S4 can reduce mortality in larvae of the Eastern oyster Crassostreae
virginica challenged with the pathogens Vibrio tubiashii and Roseovarious
crassostreae. However, the mechanisms involved in this probiotic protection remain
to be elucidated. In this study, secondary metabolites produced by P. gallaeciensis S4
were investigated for their contributions to larval protection. Using a bioassay-guided
fractionation approach, it was found that the S4 strain produces tropodithietic acid
(TDA) and that this compound has potent antibiotic properties against the marine
pathogens V. tubiashii, R. crassostreae, and V. anguillarum. A series of mutants of S4
(tdaA-, tdaB-, tdbD-, clpX-, rpoE-, exoP) were tested for their production of TDA. The
tdaA-, tdaB-, tdbD-, and clpX- mutants lost the ability to produce TDA, while the rpoEand exoP- strains produced TDA at levels similar to the wild-type strain. The tdaA-,
tdaB-, tdbD- strains were deficient in TDA production and had 70-80% reduction in
biofilm formation. The clpX- strain maintained its ability to form a normal biofilm,
while the exoP- strain was biofilm deficient. In further collaboration with the
laboratory of Dr. Marta Gomez-Chiarri at URI, challenge assays were conducted using
oyster larvae, V. tubiashii, and the clpX-, exoP-, and wild-type strains. These in vivo
experiments revealed that both TDA production and biofilm formation contribute to
the probiotic activity of P. gallaeciensis S4.
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Introduction
Bacteria belonging to the genus Phaeobacter have shown promise as probiotic
agents for aquaculture. Phaeobacter are α-proteobacteria belonging to the Roseobacter
clade, which comprises the majority of oceanic bacterioplankton (Liang 2003,
Brinkhoff, Bach et al. 2004, Porsby, Nielsen et al. 2008, Porsby, Webber et al. 2011).
Previous studies have reported several Roseobacter isolates that exhibit antagonistic
effects against pathogenic Vibrio species that are problematic in cod and turbot
larviculture (Brinkhoff, Bach et al. 2004, Bruhn, Nielsen et al. 2005, Porsby, Nielsen
et al. 2008, Porsby, Webber et al. 2011, D'Alvise, Lillebo et al. 2012).

In the last two decades, there has been an increased incidence of disease
outbreaks by oyster pathogens (Boettcher, Geaghan et al. 2005, Gomez-Leon, Villamil
et al. 2008, USDA 2008, NOAA 2012). Some of these diseases are detrimental to
hatchery production of larvae and can subsequently impact shellfish production by
farmers. In particular, pathogen outbreaks of Vibrio spp. can have devastating effects
on oyster larviculture (Romalde and Barja 2010). In 2006, Vibrio outbreaks were
reported to have caused a 59% decline in oyster larvae production (Balcazar, de Blas
et al. 2006). Other infectious diseases also affect the shellfish industry. Outbreaks of
the bacterial pathogen Roseovarious crassostreae can cause up to 90% losses of total
production. New disease management tools are required to combat pathogen outbreaks
in shellfish aquaculture facilities.

The treatment of pathogenic disease in aquaculture is problematic due to
limited resources and treatment options (Decamp, Moriarty et al. 2008). Filtration, UV
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irradiation, ozonolysis, and electrolysis of incoming seawater have all been explored
to reduce the risk of introducing pathogens to hatcheries. However, all of these
methods have drawbacks, mainly high costs (Meunpol, Lopinyosiri et al. 2003, Park,
Kim et al. 2011). Seawater filtration using a 1µm filter cartridge and followed by
exposure to UV irradiation (30,000 µWs-1cm-2) prevented infection of oyster juveniles
by both eukaryotic parasites H. nelsoni and Perkinsus marinus, the causative agent for
Dermo disease (Ford, Xu et al. 2001). Filter sterilized seawater has yielded good
results in preventing Juvenile Oyster Disease JOD in cultures of the Eastern oyster C.
virginica (Boettcher, Barber et al. 1999). Ozonation in freshwater recirculating
hatchery systems has been used for almost 30 years to control bacterial disease (Park,
Kim et al. 2011). There have been some conflicting reports that ozonation in seawater
can have toxic effects due to a reaction with bromine (Park, Kim et al. 2011).
Electrolytic methods have been successful in reducing microalgae, bacteria, and
viruses (Jorquera, Valencia et al. 2002, Wijesekara, Nomura et al. 2006, FAO 2014).
Despite some success in water treatment, shellfish hatcheries are still impacted by
disease outbreaks. Vaccines are not feasible in bivalves and overuse of antibiotics
can promote drug resistance. In order to minimize this threat, new alternatives must
be sought out for disease management.
Probiotics have shown promise as a disease management tool for aquaculture,
particularly in shrimp (Rengpipat, Phianphak et al. 1998, Farzanfar 2006, Decamp,
Moriarty et al. 2008). They are defined by the World Health Organization to be ‘Live
microbes which have a beneficial effect on the host’(Liang 2003). They are a “green”
alternative to the use of antibiotics since they are unlikely to contribute to the rising
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problem of antimicrobial resistance. Marine probiotics have several proposed modes
of action, including the production of antimicrobial compounds, competition for
adhesion sites and nutrients, stimulation of the host immune system, and enhancement
of nutrition for the host (Queiroz and Boyd 1998, Murthy and TJ 1999, Ziaei-Nejad,
Rezaei et al. 2006, Kesarcodi-Watson, Kaspar et al. 2008, Cude, Mooney et al. 2012).
Unlike chemical antibiotics, probiotics are provided to larvae prior to infection
outbreaks in order to control pathogens in the aquaculture setting.
Previously, Phaeobacter gallaeciensis S4 was isolated from the inner shell
surface of an apparently healthy oyster. Phaeobacter spp. can form rosettes, are
excellent biofilm formers, and are considered to be dominant colonizers of surfaces in
marine environments. When S4 was used as a potential probiotic treatment of oyster
larvae, it showed strong antagonistic properties against pathogens and increased host
survival in the presence of bacterial pathogens. S4 can be used to mitigate the effects
of several important diseases, but little is known about the probiotic mechanisms of
action (Karim, Zhao et al. 2013). In this study, we examined the roles of antibiotic
production and biofilm formation in the probiotic activity of P. gallaeciensis S4.
Bioassay-guided fractionation was used to isolate tropodithietic acid (TDA), a potent
antibiotic against important marine pathogens. Using a series of gene-knockout
experiments and in vivo challenges with oyster larvae, the contributions of TDA and
biofilm production by S4 were individually interrogated for their contributions to the
probiotic activity of S4.

Methods and Materials
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General Experimental Procedures
1

H NMR spectra were recorded in benzene-d6 at 20 °C on a Varian 500 MHz

VNMRS spectrometer (Agilent Technologies, Wilmington, DE USA). Chemical shifts
were referenced with to the solvent signal at δH 7.16. Data processing was performed
using VNMRJ software (Agilent Technologies, Wilmington, DE USA). ESIMS of the
purified compound was measured using an AB Sciex QSTAR Elite quadrupole timeof-flight (qTOF) mass spectrometer (m/z 5-40,000) equipped with a Turbo Ion Spray
source (AB Sciex, Framingham, MA USA). Preparative high-pressure liquid
chromatography HPLC was conducted on a Hitachi Elite LaChrom system consisting
of a L2130 pump, L-2200 autosampler and an L-2455 diode array detector. Data
processing was performed on EZ Chrom Elite software (Hitachi Santa Clara, CA
USA). The HPLC analysis was carried out on a Waters Xterra 5µm C18 100 x 3.0
mm column (Milford, MA USA). UHPLC experiments were conducted using a
Hitachi La Chrom Ultra® equipped with a diode-array detector L2445U, a column
oven L-2300, an auto sampler L-2200U, two L2160U pumps, and a Fortis® (Cheshire,
CH64 3UG) 1.7µ 2.1x50 mm C18 column connected to a 3 µ C18 guard column.
Bacteria strains and cultivation
Phaeobacter gallaeciensis S4, R. crassostreae Cv 919-312T and V. tubiashii
RE22 were provided by Dr. Marta Gómez-Chiarri (University of Rhode Island), and
Vibrio harveyi BB120 was provided by Dr. David Nelson (University of Rhode
Island). P. gallaeciensis S4 mutant and complement strains (tdaA-, tdaB-, tdbD-, clpX and exoP-) were provided by Dr. Wenjing Zhao and Dr. David Nelson (University of
Rhode Island). All bacteria were cultured in a seawater-based yeast extract-peptone
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culture medium [YP; 5 g/L of peptone (Sigma Aldrich, St. Louis, MO USA), 1 g/L of
yeast extract (Becton, Dickinson and Co, Franklin Lakes, NJ USA), and 30 g/L of
Instant Ocean (United Pet Group Inc., Cincinnati, OH USA) in pure, reverse osmosis
(RO) water] at 28 °C with shaking at 175 rpm. Bacterial stocks were stored at −80 °C
in YP broth with 25% glycerol until use.
Purification and identification of bioactive molecule from Phaeobacter
gallaeciensis S4
P. gallaeciensis S4 was cultured in 7 x 1 L volumes of YP liquid culture
medium at 28 °C with shaking at 175 rpm. After 96 h, the cells were pelleted by
centrifugation at 10,000 rpm for 10 min. The resulting culture supernatants were
acidified to pH 3 with formic acid (FA) (Sigma Aldrich, St. Louis, MO USA) and
extracted with acidified (0.1% FA) ethyl acetate. The ethyl acetate extract was
concentrated in vacuo to yield 0.673 g of crude extract. The extract was fractionated
using C18 flash chromatography (Redi sep Rf high performance gold 30g hp
combiflash column; linear gradient elution 5% - 100% CH3OH in H2O, 0.1% FA, 45
min). This led to fractions containing pure TDA, which was identified based on
comparison of 1H NMR and ESIMS data with literature values. To construct a
standard curve for determining concentrations of TDA, solutions of pure TDA in
methanol (MeOH) at various concentrations were analyzed by reversed-phased HPLC.
Eluent A was Milli-Q water acidified with 0.1% FA and eluent B was HPLC grade
methanol acidified with 0.1% FA. The method program was a linear gradient of 5% to
100% eluent B over 9 min. The injection volume was 3 µL and the flow rate was 0.25
mL/min. All chromatograms were analyzed at a wavelength of 302 nm for detection of
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TDA (tR = 7.35 min). Each concentration was analyzed in triplicate, and averages were
calculated for the peak areas. A standard curve was constructed by plotting peak area
versus concentration.
Disc Diffusion assay
Extracts were dissolved in MeOH at 25 mg/mL and 10 µL of the sample was
pipetted onto a paper disc and allowed to dry (250 µg/disc). Meanwhile, overnight
culture of V. harveyi BB120 was swabbed onto YP plates. Discs were laid onto the
agar surface and the plates were incubated for 24 h at 28 °C. Zones of growth
inhibition were measured in mm.
Minimum inhibitory concentration (MIC) assay
The MIC of TDA was determined against V. tubiashii and V. anguillarum
following standard protocols (Andrew 2001). Briefly, 5 µL of a two-fold serial
dilution of TDA in methanol was added to wells of a 96 well microtiter plate. The
final concentration of TDA in the well ranged from 25 µg/mL to 0.196 µg/mL. V.
tubiashii RE22 or V. anguillarum (195 μL, 105 CFU/ mL) was added to the wells
containing TDA. Control wells received 5 µL MeOH, tetracycline (antibiotic control,
concentrations from 20 µg/mL to 0.391 µg/mL) or negative control (YP media only).
All treatments or controls were tested in triplicate. The plate was incubated at 30 °C
for 24 h. The presence or absence of V. tubiashii RE22, V. anguillarum growth was
determined visually after 24 h. The MIC was defined as the lowest concentration of
antibiotic resulting in no visible bacterial growth.
Construction of mutant strains of Phaeobacter gallaeciensis S4
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S4 mutant strains were created to investigate the role of TDA in the probiotic
activity of P. gallaeciensis S4. The mutant S4 strains (tdaA-, tdaB-, tdbD-, clpX-, rpoE-,
exoP-) and complement strains (clpX+ and exoP+) were constructed and provided by
the Nelson laboratory (Cell and Molecular Biology Department, University of Rhode
Island). Briefly described below are the methods for the construction of the mutant
strains and the complement mutation strains by Dr. Wenjing Zhao and Dr. David
Nelson.
Insertional mutagenesis
Insertional mutagenesis by homologous recombination was used to create
interruptions within specific genes using a modification of the procedure described by
Milton and Wolf-Watz (Milton, O'Toole et al. 1996, Li, Mou et al. 2011). Briefly,
primers (Table 1) were designed to amplify specific Phaeobacter genes based on
homologous sequences from P. gallaeciensis 2.10 (GenBank accession
No.CP002972.1). A fragment of the selected gene was PCR amplified, then digested
with SacI and XbaI restriction enzymes, and the DNA fragments separated on a 1%
agarose gel. Subsequently, the gel-purified PCR fragment was ligated into the suicide
vector pNQ705 after digestion with SacI and XbaI and the ligation mixture was
introduced into E. coli Sm10 (λ pir) by electroporation with Bio-Rad Gene Pulser II.
The resulting recombinant plasmids were confirmed by both PCR amplification and
sequencing. The mobilizable suicide vector was transferred from E. coli Sm10 (λ pir)
into S4Sm by conjugation. Transconjugants were selected by utilizing the
chloramphenicol resistance gene located on the suicide plasmid. The incorporation of
the suicide vector into the gene of interest was confirmed by PCR analysis and DNA
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sequencing.

Complementation of mutants
P. gallaeciensis mutants were complemented by cloning the appropriate gene
fragment into the shuttle vector pBBR1MCS4 (GenBank accession No. U25060),
using a modification of the method described previously by Rock and Nelson (Rock
and Nelson 2006). Briefly, primers (Table 1) were designed with a SacI or XbaI site
added to the 5’ end of the appropriate primer. The primer pair was then used to
amplify the entire gene plus ∼500 bp of the 5′ and 3′ flanking regions from genomic
DNA sequences of P. gallaeciensis 2.10 (GenBank accession No.CP002972.1). The
resulting amplicon was ligated into the pBBR1MCS4 plasmid after digestion with
SacI and XbaI and the ligation mixture introduced into E. coli Sm10 (λ pir) by
electroporation with Bio-Rad Gene Pulser II. Transformants were selected on LB10Amp100 agar plates and the recombinant plasmids confirmed by both PCR
amplification and sequencing. The complementing plasmid, pBBR1MCS4-clpX or
pBBR1MCS4-exoP, was transferred from E. coli Sm10 into clpX or exoP mutants by
conjugation using the procedures described previously. The transconjugants were
confirmed by PCR amplification.
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Table 1. Primers used to construct S4 genetic knock out mutants

Sequence (5' to 3', underlined sequences are engineered
restriction sites)
pw108
GAAGAGCTCGGACGACTATGTGATTGGTCAGGC
pw109
GGGTCTAGACGACGTTATATTCCGACGCCTGCA
pw153
GTATTAGAGCTCGAGCATAACCGCTTTGCCCGCCGCCCA
pw154
CGACTATCTAGACCATGCTGAGTGCAAGGTTGACGGCGG
pw127
GCATTAGAGCTCGTCAGATTGGCCGAAGCCCCTTTT
pw128
CGGCTATCTAGACGAACTCACCACCTGAGGAGATACGT
pw166
GTATTAGAGCTCCCCGTCCGATGTGTCAAAATAGGT
pw165
CGTCTTTCTAGAGGTGCCTGCGGTCATCACCATGAC
pwGFP-F GCGGTACATATGTAAGGAGGAAAAACATATG
pwGFP-R CTATATGGATCCCAGATCTATTTGTATAGTTCATCCA
Pm113
GGTACCTGTCTGTCGCCTCTTGT
Pm114
GGTACCATATCATTCCTCCATGAT
pwmO-F GCGGTACATATGATGGTGAGCAAGGGCGAGGAGAAT
pwmO-R CTATATGGATCCCTTGTACAGCTCGTCCATGCCGCC
Primer

Description
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For clpX insertional mutation, forward, with SacI site
For clpX insertional mutation, reverse, with XbaI site
For exoP insertional mutation, forward, with SacI site
For exoP insertional mutation, reverse, with XbaI site
For clpX in trans complement, forward, with SacI site
For clpX in trans complement, reverse, with XbaI site
For exoP in trans complement, forward, with SacI site
For exoP in trans complement, reverse, with XbaI site
For amplification of gfp ORF, forward, with NdeI site
For amplification of gfp ORF, reverse, with BamHI site
For amplification of PflaB, forward, with KpnI site
For amplification of PflaB, forward, with KpnI site
For amplification of ofp ORF, forward, with NdeI site
For amplification of ofp ORF, reverse, with BamHI site

Chemical Extraction of wild type strain and mutant strains
S4 wild type and S4 mutant strains (tdaA-, tdaB-, tdbD-, clpX-, rpoE-, exoP- and
complement strains clpX+ and exoP+) were cultured in triplicate in 50 mL cultures
(YP medium, 27 °C, 175 rpm) until stationary growth phase was reached as indicated
by an OD600 absorbance of 0.7-0.8 (108 CFU). The cells were pelleted by
centrifugation (4,000 rpm, 10 min). The supernatants were passed through a 0.2
micron filter, acidified to pH 3 with FA, and extracted twice with 50 mL of acidified
(0.1% FA) ethyl acetate. The two organic layers for each culture were combined and
dried in vacuo at 27 °C, yielding 27 crude extracts. The procedure was additionally
used to prepare and analyze culture extracts of the S4 wild type and tdaA-, tdaB-, tdbD, clpX-, rpoE-, and exoP- mutants at 6 h and 24 h time points, yielding an additional 42
extracts.
HPLC Detection of TDA in S4 wild type and tdaA-, tdaB-, tdbD- extracts
S4 culture extracts (wild type, tdaA-, tdaB-, and tdbD-) were prepared in 10
mg/mL solutions in HPLC grade MeOH. The extracts were analyzed by reversedphase HPLC system equipped with a diode array detector (DAD) and Xterra 5µm C18
100 x 3.0 mm column. Eluent A was Milli-Q water acidified with 0.1% FA and eluent
B was HPLC grade methanol acidified with 0.1% FA. The program was a linear
gradient of 5% to 100% eluent B over 24 min. The injection volume was 10 µL and
the flow rate was 0.5 mL/min. Spectra were analyzed at a wavelength of 302 nm for
optimal detection of TDA.
UHPLC Detection and Quantification of TDA in P. gallaeciensis S4 culture
extracts
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The analysis of the crude extracts was also conducted using reversed-phase UHPLC.
S4 culture extracts (wild type, clpX-, rpoE-, and exoP-) were prepared in 10 mg/mL
solutions in HPLC grade MeOH. Eluent A was Milli-Q water acidified with 0.1% FA
and eluent B was HPLC grade MeOH acidified with 0.1% FA. The program was a
linear gradient of 5% to 100% eluent B over 9 min. The injection volume was 3 µL
and the flow rate was 0.25 mL/min. All chromatograms were analyzed at a wavelength
of 302 nm for detection of TDA. Each strain was analyzed in triplicate. TDA
concentrations were determined based on a standard curve.
Oyster larvae bacterial challenges
Oyster larvae challenges were performed by Sae Bom Sohn and Dr. Marta
Gomez-Chiarri (URI) as previously described (Karim, Zhao et al. 2013). Briefly,
oyster larvae (25-30) were placed in each well of a 6 well plate containing 5 mL of
fresh sterile seawater (FSSW) at 28 psu. Each treatment was run in triplicate. The wild
type S4 or mutants were added to wells at a final concentration of 105 CFU/mL.
Oyster larvae were fed with commercial algal paste (Reed Mariculture Inc., San Jose,
CA, USA) in order to promote ingestion of probiotics by the larvae while feeding.
Plates were incubated at 22-23 °C for 24 h with gentle rocking. Water was changed
after 24 h of incubation with the probiotic and V. tubiashii RE22 was added to 5 mL of
FSSW to achieve a final concentration of 105 CFU/mL. Larvae and pathogen were
incubated for an additional 24 h. In order to determine the survival of larval oysters,
200 µL of neutral red (stock concentration 13.3 mg/L) was added to each well (final
concentration of 0.53 mg//L in each well) and incubated for 2 h. The neutral red
staining technique helps to distinguish the live (stained) and dead (unstained) oysters
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(Gomez-Leon, Villamil et al. 2008). Both the survival rate (SR) and relative percent
survival (RPS) were calculated using the following formulas:
SR= (number of survivors/total number of oysters) x100
RPS = [1-(%survival challenge control oysters/% survival challenged treatment
oysters)] x100
Statistical analysis
All experiments were performed in triplicate, and a q-test was performed on
the area underneath the curve for each data set for all concentrations of the TDA
analysis. As previously described (Karim, Zhao et al. 2013), oyster challenge assays
were analyzed using One Way Analysis of Variance (ANOVA ) and multiple
comparison tests (Tukey Test) was used to determine significant level between groups.
Statistics were analyzed using Sigmastat 3.1 software (Systat) (Karim, Zhao et al.
2013).
Results
P. gallaeciensis S4 wild-type produces the antibiotic tropodithietic acid
P. gallaeciensis S4 was previously shown to inhibit the growth of several
oyster pathogens (Karim, Zhao et al. 2013). However, the identity of the putative
antibiotic was unknown. P. gallaeciensis S4 was cultured in 7 x 1 L scale for 96 h and
the cells were removed by centrifugation to prevent emulsion formation during liquidliquid partitioning. The resulting cell-free broths were extracted with acidified ethyl
acetate to yield 1.26 g of a crude extract that contained the antibiotic activity.
Antibiotic activity was assessed using a disc diffusion assay and found to reside in the
organic fraction. Further bioassay-guided fractionation was pursued by C18 medium
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pressure chromatography yielding 6 fractions. The disc diffusion tests indicated only
one active fraction (F5), which was further analyzed by analytical HPLC. This fraction
appeared to contain a single compound with a retention time of (tR= 15.1 min) and a
characteristic UV absorbance at 302 nm. Thus, this fraction afforded compound 1
shown in Figure 1 with a yield of 0.71 mg/L. The molecule was also analyzed by
UHPLC monitored at 302 nm (tR =7.35 min) as shown in Figure 2. Compound 1 was
obtained as a copper orange solid. ESIMS data showed an [M+H]+ ion at m/z 212.9,
[M+Na]+ ion at m/z 234.9, [M-COOH]+ ion at m/z 164.0 and [M-H2O]+ ion at 194.0
(Figure 3). The 1H NMR spectra (Figure 4) had three aromatic protons [δH 5.36, 5.89,
and 6.67] and one proton downfield at δH 16.77 (Table 1). The 1H NMR data and the
ESIMS data were consistent with literature values for tropodithietic acid (TDA) which
has a molecular formula of C8H4O3S2 (Figure 1) (Liang 2003). Pure TDA had a MIC
of 6.25 µg/mL (29.5 µM) against V. tubiashii and 2.38 x10-3 µg/mL (0.011 µM)
against V. anguillarum.

(1)
Figure 1. Structure of Tropodithietic Acid (1)
53

Figure 2. UHPLC chromatogram of pure TDA monitored at 302 nm.
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Figure 3. ESIMS of purified TDA in the positive ion mode.
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Figure 4. (a) 1H NMR of spectrum for purified TDA in C6D6. Region of spectrum showing resonances shown. (b) Expanded
1

H NMR of spectrum for purified TDA in C6D6 from 5-7 ppm.

Table 2. 1H NMR spectroscopic data of TDA (1)
H
δH, m, J=Hz literature (Liang
2003)
5
1H, 5.38, d, J=8.9
6
1H, 5.90, dd, J=12.2, 8.9
7
1H, 6.63, d J=12.2
8
1H, 16.80 s

δH m, J=Hz experimental
1H, 5.36, d J=9.0
1H, 5.89, dd, J=12.1, 8.8
1H, 6.67, d, J=12.5
1H, 16.77 s

Construction and chemical extraction of mutant strains of P. gallaeciensis S4
Mutant strains were constructed to understand the contribution of biofilm
formation and antibiotic production toward probiotic activity. Target genes were those
associated with biofilm production and antibiotic production. Six mutant strains of P.
gallaeciensis S4 (tdaA-, tdaB-, tdbD-, clpX-, rpoE-, and exoP-) were created and
provided by Dr. Wenjing Zhao and Dr. David Nelson. Organic extracts were generated
from 50 mL cultures and analyzed by analytical HPLC and/or UHPLC for the
presence of TDA. HPLC analysis of tdaA-, tdaB- and tdbD- extracts confirmed the lost
production of TDA when compared to S4 wild type crude extract (Figure 5). UHPLC
analysis of clpX- extract also confirmed the lost production of TDA (Figure 9). Thus, it
was concluded that the tdaA, tdaB, tdbD and clpX genes are all required for the
biosynthesis of TDA. UHPLC analysis of the rpoE- and exoP- mutants confirmed that
these genes are not required for TDA production. TDA was produced at all-time
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points (6h, 24h and stationary phase) with a retention time of TR = 7.35 min (Figure
6).

TDA

Figure 5. HPLC analysis of P. gallaeciensis S4 wild type and mutant strains
tdaA-, tdaB-, tdbD- monitored at 290 nm.
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S4 wild type

Strain rpoE-

Strain exoP-
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S4 wild type
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Figure 6. (a). UHPLC of S4 wild type and mutant strains rpoE- and exoP- at stationary phase monitored at 302 nm (b) UHPLC
of P. gallaeciensis S4 wild type and rpoE- and exoP- mutant strains at 6 hours. TDA production (peak at TR= 7.35 minutes)
was monitored at 302nm. (c) UHPLC of P. gallaeciensis S4 wild type, rpoE- and exoP- strains at 24 hours.

P. gallaeciensis S4 wild-type is an excellent biofilm former
The crystal violet staining assay was used to demonstrate that S4 wild-type
produced thick biofilms. The absorbance (OD580 value) for S4 wild type strain was
measured to be 3.89+0.06 at 27 C under static conditions after 60 h (Table 3). As
expected, the absorbance of (OD580 value) of rpoE- and clpX – strains were similar to
the S4 wild-type. The exopolysaccharide exoP gene was predicted to be involved in
biofilm formation. This was confirmed by a low absorbance (OD580 value = 1.60+
0.09) of the mutant exoP – strain when compared to the wild type shown in Table 3.
The complement mutant exoP+ should have re-inserted the gene exoP, thus restoring
biofilm formation. The complement mutant exoP+ demonstrated that gene exoP was
successfully re-inserted, due to biofilm formation similar to the wild type, as shown in
Table 3. In contrast, all three pathogens (V. anguillarum, V. tubiashii, and R.
crassostreae) used in this study had biofilms that were between 13.4-14.9% of the S4
wild type (Table 3). These data suggested S4 has the ability to form thick and dense
biofilm matrix on glass coverslips.

Creation of a standard curve of pure TDA

A standard curve was constructed using pure TDA to quantify concentrations
of the antibiotic in bacterial culture extracts. A total of 11 concentrations of TDA
ranging from 1000 µg/mL to 0.97 µg/mL were prepared in 2-fold serial dilution. The
analysis of all TDA concentrations was carried out by reversed-phase UHPLC in
triplicate. Before the standard curve was constructed a q-test was performed on the
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area underneath the peak for each data set for all concentrations (1000 µg/mL – 0.97
µg/mL). All concentrations were determined to have a 95% confidence interval. The
variation between each sample was <10% difference. A graph was constructed of
average peak area versus concentration and a linear regression trend line was added
(Figure 7). All of the concentration data points fit well with the linear regression trend
line, shown by the r2 value = 0.998.
Table 3. Quantification of biofilm formation by measuring OD580 of crystal violet
dye assay.

Strains

OD580*

P. gallaeciensis S4Sm
P. gallaeciensis WZ10 (clpX-)
P. gallaeciensis WZ11 (clpX+)
P. gallaeciensis WZ20 (exoP-)
P. gallaeciensis WZ21 (exoP+)
V. anguillarum NB10Sm
V. tubiashii RE22Sm
R. crassostreae CV919Sm

3.89±0.06
3.90±0.12
4.0±0.06
1.60±0.09a
3.90±0.10
0.58±0.02a
0.54±0.02a
0.52±0.08a

*Biofilm formation quantified by crystal violet dye assay as described in the Materials
and Methods. The data presented are the average of two independent experiments and
each independent experiment has three replicates.
a

Statistically significant difference compared to S4 wild-type.
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Figure 7. Standard curve of TDA based on UHPLC analysis of pure TDA in concentrations ranging from 1000 µg/mL to
0.97µg/mL.

Quantification of TDA in S4 wild-type and mutant strains of rpoE- and exoPUHPLC analysis of S4 wild type, rpoE-, and exoP- extracts at all-time points
confirmed the production of TDA (Table 4). At the first time point (6 hours), the S4
wild type had produced the highest amount of TDA at all time points (Table 4 and
Figure 8). The concentration of TDA at both 24 h and the stationary phase is 4-5 times
the MIC against V. tubiashii.

Table 4. Quantification of TDA in strains of P. gallaeciensis S4 in 50 mL cultures at
three time points.
Bacterial Strain

Quantity of TDA produced (µg/mL)
6h
24h
27h

Wild type S4

4.16+0.07

32.60+0.73

21.80+2.35

exoP-

0.45+0.12

30.70+2.61

18.70+0.08

rpoE-

2.47+0.11

24.80+1.61

14.20+0.52

TDA production detected using UHPLC analysis and compared to a standard curve
described in the Materials and Methods. The data presented are the average of two
independent experiments and each independent experiments has three replicates.
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Figure 8. TDA production by S4 wild type, rpoE- and exoP- strains cultured in 50 mL scale, YP medium, at 6h, 24 h, and
stationary phase (~27 h).

Detection of TDA in culture supernatants of clpX- and exoP- strains and
complement clpX+ and exoP+ strains
UHPLC analysis of culture extracts from the clpX – mutant confirmed that this
gene is required for optimal TDA production. Analysis of the clpX+ strain confirmed
that reinsertion of this gene restored TDA biosynthesis. TDA production was
observed for both the exoP- and exoP+ strains (Figure 9). Together, these results
confirm that genes tdaA, tdaB, tdbD and clpX, but not exoP, are necessary in the
biosynthesis of TDA by P. gallaeciensis S4. These results were in agreement with
Geng et al (Geng, Bruhn et al. 2008).
TDA
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exoPclpX+
clpXTDA

Figure 9. Detection of TDA in culture supernatants of clpX- and exoP- strains and
complement strains clpX+ and exoP+.
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Mutations in tdaA, tdaB and tdbD affect probiotic activity of P. gallaeciensis
against V. tubiashii in oyster larvae.
Karim et al. (2013) demonstrated that S4 wt provides protection to oyster
larvae against infections by V. tubiashii RE22 (Karim, Zhao et al. 2013). Oyster
challenge assays were performed with both wt and mutant strains to determine if TDA
production and biofilm formation are necessary for probiotic activity against V.
tubiashii. P. gallaeciensis S4 mutants tdaA-, tdaB- and tdbD- provided partial
protection to the oysters against V. tubiashii challenge compared to wild-type S4. The
tdaA-, tdaB- and tdbD- mutants showed a >50% decline in oyster larvae survival
compared to S4 wild-type as shown in Table 4. S4 mutants tdaA-, tdaB- and tdbDprovided slight protection of the oyster larvae compared to the survival of larvae
treated only with the RE22 pathogen.

Mutations in clpX and exoP affect probiotic activity of P. gallaeciensis against V.
tubiashii in oyster larvae.
To further assess if mutations in TDA production or biofilm formation would
affect the probiotic activity of S4 against V. tubiashii in vivo, oyster challenge assays
were performed with the exoP (biofilm deficient) and clpX (TDA deficient) mutants.
Both P. gallaeciensis mutants showed a partial protection of the oysters against V.
tubiashii challenge compared to wild type. The clpX mutant exhibited a >50% decline
in oyster larvae survival compared to S4 wild type (RPS, S4 wild type: 72% ± 1% vs.
clpX-: 35% ± 3%), while the exoP mutant provided almost 70% of the protection as
wild type (wild type: 72% ± 1%; exoP-: 50% ± 8 %) (Table 5). The RPS increases in
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larval survival provided by clpX- and exoP- mutants were equal to 35% ± 3% and 50%
± 8%, respectively.

Table 5. Effect of a 24 h preincubation with Phaeobacter gallaeciensis S4 wild-type
or mutant strains on oyster larval survival 24 h after challenge with the bacterial
pathogen Vibrio tubiashii RE22.

Quantity of TDA

Relative Percent Survival

produced at 24 h (µg/mL)

(%RPS)*

Wild type

32.60+ 0.73

72+1

tdaA-

NP

24+2

tdaB-

NP

24+4

tdbD-

NP

23+2

clpX-

NP

35+3

exoP-

30.70+ 2.61

50+8

P. gallaeciensis S4 strains

*Larval oysters were challenged using the protocol described above in the Methods
and Materials. These experiments are representative of at least 3 independent
replicates.
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Discussion
Probiotics have been hypothesized to possess several modes of action,
including colonization, biofilm formation, production of antibiotic molecules,
immunostimulation of the host, and enhanced water quality (Verschuere, Rombaut et
al. 2000, Vine, Leukes et al. 2006, Kesarcodi-Watson, Kaspar et al. 2008). In this
study, mutant strains of P. gallaeciensis S4 that were deficient in TDA production or
biofilm formation were constructed and analyzed. After the confirmation of these
either loss in TDA production or variations in biofilm formation these strains were
tested for the ability to provide protection of C. virginica larvae when challenged with
V. tubiashii. This study confirmed that antibiotic production and biofilm formation
were found to be critical factors in probiotic protection of oyster larvae afforded by P.
gallaeciensis S4..

Our research confirms the role of TDA in the probiotic activity for
Phaeobacter sp. strain (S4). Roseobacter isolates have been shown to produce
tropodithetic acid (TDA), an antibiotic with potent effects against marine and human
pathogens (Kintaka, Ono et al. 1984, Kawano, Nakagomi Kazuya. et al. 1998, Gram,
Melchiorsen et al. 1999, Brinkhoff, Bach et al. 2004, Bruhn, Nielsen et al. 2005, Geng,
Bruhn et al. 2008, Porsby, Nielsen et al. 2008). Liang (2003) originally isolated and
described TDA from Roseobacter gallaeciensis. The structure of TDA was reported to
be a tropolone fused to a four-membered ring incorporating a disulfide (Brinkhoff,
Bach et al. 2004, Bruhn, Nielsen et al. 2005, Porsby, Webber et al. 2011, D'Alvise,
Lillebo et al. 2012). TDA may convert to thiotropocin, another broad-spectrum
antibiotic. The structure of thiotropocin is a tropolone attached to a five-membered
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thiolactone ring (Kintaka, Ono et al. 1984, Cane, Wu et al. 1992, Bentley 2008). TDA
and thiotropocin have been proposed as tautomers of each other (Bentley 2008, Greer,
Aebisher et al. 2008, Porsby, Webber et al. 2011, Seyedsayamdost, Carr et al. 2011).

In addition to producing TDA, Phaeobacter species are typically excellent biofilm
formers, colonizing a variety of surfaces including microalgae and shells (Belas,
Horikawa et al. 2009, Prado, Montes et al. 2009, D'Alvise, Melchiorsen et al. 2010).
Biofilms can be formed from compact bacteria communities that adhere to surfaces.
Bacterial biofilms are thought to be linked to chronic or persistent diseases found in
both marine and human environments (Hancock, Dahl et al. 2010). In this study,
mutation in the exoP gene was found to reduce biofilm formation by ~60%, but
production of TDA was unaffected at (24 h). Loss of optimal biofilm production
resulted in reduction of probiotic protection of larval oysters from V. tubiashii
infections when tested in vivo. These results demonstrate the requirement for biofilm
formation to provide maximum probiotic effects.

Pure TDA exhibited antibiotic effects toward V. tubiashii and V. anguillarum in vitro,
suggesting that it plays a role in animal protection. To determine the role of TDA
production and biofilm formation in the probiotic activity of S4, mutant strains (tdaA-,
tdaB-, tdbD-, clpX, rpoE,- and exoP-) were created and subjected to chemical analysis.
Genes tdaA, tdaB, clpX and rpoE were previously found to be necessary for the
biosynthesis of TDA in Silicibacter sp. TM104 (Geng, Bruhn et al. 2008, Karim, Zhao
et al. 2013), so these were an initial focus for this study. These genes have roles in ring
precursors, oxidation and expansion and regulatory mechanisms for synthesis of TDA.
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Gene rpoE is an alternative sigma factor for RNA polymerase, it has a possible role in
regulation of gene expression (Geng, Bruhn et al. 2008, Rattanama, Thompson et al.
2012). This study confirmed that the genes tdaA, tdaB and tdbD are necessary for
TDA biosynthesis, but mutations in these genes resulted in strains that also displayed a
70-80% reduction in biofilm formation. Thus, these mutations were not suitable for
dissecting the independent contributions of biofilm capability and antibiotic
production. However, mutation in clpX (an ATP-binding protein regulatory subunit)
resulted in lost production of TDA but had no effect on biofilm formation. In vivo
testing of this mutant also resulted in only partial protection of oyster larvae, further
suggesting that TDA production plays a role in the probiotic activity of P.
gallaeciensis S4. Treatment of oyster larvae with sub-MIC levels of TDA (3.25 µg/mL
and 1.56 µg/mL) also provides partial protection following challenge with V. tubiashii
(Karim, Zhao et al. 2013). It is possible that there are other contributing factors
besides antibiotic production and biofilm formation leading to probiotic activity for P.
gallaeciensis S4.
TDA was present in all of the growth phases of S4 wild type, rpoE- and exoP-.
It appears that the TDA is produced in the highest concentration at 24 h in all strains,
which was considered the late exponential phase. A decline in TDA concentration
appears during the stationary phase, and this may correspond to degradation of the
molecule, or a down regulation of the genes responsible for TDA biosynthesis. While
mutations in tdaA, tdaB, tdbD, clpX, exoP and rpoE all resulted in reduced protection
of larval oysters when challenged with V. tubiashii, each still provided a higher
relative percent survival than oysters treated with V. tubiashii only. It is possible that

72

these mutants may act by modulating the immune response of the larvae, or that other
yet unidentified mechanisms of probiotic activity maybe also involved. This study
strongly supports that the production of TDA and the ability to form biofilms
contribute to the probiotic effects of P. gallaeciensis S4 in oyster larviculture.
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Abstract
Probiotic agents are promising tools to reduce the risks of disease outbreaks in
aquaculture facilities. However, there are currently no commercially available
probiotics for shellfish aquaculture. The marine bacterium Bacillus pumilus RI0695
was previously reported to provide significant protection of Eastern oyster,
Crassostreae virginica, larvae when challenged with the shellfish pathogen Vibrio
tubiashii. This investigation aimed to create a stable formulation of B. pumilus RI0695
for delivery to larval tanks at shellfish hatcheries. Granulation is a proven and cost
effective method of formulation. A granular probiotic formulation of B. pumilus
RI0695 was created by extruding dried B. pumilus RI0695 cells through three particle
size sieves (40s, 80s, and 325s) resulting in 420 µ, 177 µ and 43 µ granule sizes. The
43 µ and 177 µ granular formulations stored at 27° C and sampled at 22 weeks and 29
weeks reduced mortality in C. virginica larvae and seed when challenged with V.
tubiashii. This study suggests that the 43 µ and 177 µ granular formulations of B.
pumilus RI0695 are good candidates for commercial use in shellfish hatcheries.

Introduction
The world’s aquaculture production is a multi-billion dollar industry. In 2010,
the Fisheries and Aquaculture Organization (FAO) released an overview of major
trends and issues which estimated aquaculture production to be worth 130.2 billion
USD worldwide (FAO 2014). The United States is a significant contributor to both
fresh and marine aquaculture sales by adding approximately one billion dollars to the
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worldwide total (Elston, Hasegawa et al. 2008). Aquaculture sales in Rhode Island
have dramatically increased from $83,518 in 1995 to $2.8 million in 2012. In 2012,
nearly 4.3 million oysters were produced via aquaculture in Rhode Island (Beutel
2013).
Rigorous culture of bivalve shellfish on a production scale was developed in
the 1970’s. Currently, hatcheries and nurseries in the United States produce large
numbers of a variety of oysters, clams and scallops species (Elston 1998). However,
hatchery operations are especially prone to bacterial diseases that rapidly kill larvae.
Infectious diseases in the hatcheries have serious impacts on production, with 45.5%
of losses in aquaculture being due to diseases (Elston 1998, FDA 2012).
Vibriosis and Juvenile Oyster Disease (JOD) are two prevalent diseases
observed in hatcheries and nurseries (respectively) culturing the Eastern oyster
Crassostrea virginica in the Northeastern US. Vibrio species are responsible for
disease outbreaks in bivalve larviculture hatcheries. Vibriosis, or bacillary necrosis,
in larvae yields massive mortality rates in contaminated hatcheries. Vibriosis in
larvae is characterized by mantle and feeding disruption, loss of motility, and visceral
damage, usually resulting in larval death within 24 hours (Porsby, Nielsen et al.
2008). In 2006-2007, vibriosis outbreaks caused by Vibrio tubiashii spread through
hatcheries and nurseries in North America causing a 59% decline in oyster larvae
production (Elston, Hasegawa et al. 2008). Metalloprotease and hemolysin are two
virulence factors associated with the pathogenicity of V. tubiashii (Hasegawa, Lind et
al. 2008, Porsby, Nielsen et al. 2008).
The bacterium Roseovarious crassostreae is the causative agent of Juvenile
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Oyster Disease (JOD). JOD is endemic to New York and the New England area
(NOAA 2009, Romalde and Barja 2010). JOD has been responsible for mortalities of
over 90% in areas that have been infected with the disease. Indications of the disease
are reduced growth of the oyster along with uneven shell growth. JOD follows a
seasonal pattern, with most mortality occurring in middle to late summer, coinciding
with warm water temperatures. The disease can be transmitted from oyster to oyster,
but the toxins and virulence factors are still unknown for this invasive pathogen
(NOAA 2009, Romalde and Barja 2010). Although not reported to be problematic in
oyster hatcheries, R. crassostreae is able to cause mortality of oyster larvae in
experimental challenges (Gomez-Leon et al. 2008).
The use of marine probiotics is being explored as a new disease management
tools. Several in vivo studies have shown promise toward the development of probiotic
agents in shellfish, particularly in crustaceans. Moriarty and others determined
Bacillus sp. were active against V. harveyi in shrimp aquaculture (Moriarty 1998,
Meunpol, Lopinyosiri et al. 2003, Vaseeharan and Ramasamy 2003, Gullian,
Thompson et al. 2004). Alavandi et al. examined two candidate probiotics,
Pseudomonas sp. PM11 and Vibrio fluvalis sp. PM 17, for their ability to cause
immunostimulation in shrimp (Alavandi, Vijayan et al. 2004). Gibson et al.
demonstrated that probiotic candidate Aeromonas media sp. 199 produced an
inhibitory substance that contributed to the antagonistic effects in vitro as well in vivo
(Gibson, Woodworth et al. 1998). Bacillus spp. bacteria have shown promise as
probiotic agents in crustacean, and mollusk aquaculture (Queiroz and Boyd 1998).
Several species of Bacillus have also been used to increase the survival of crustaceans
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(Queiroz and Boyd 1998, Rengpipat, Phianphak et al. 1998, Meunpol, Lopinyosiri et
al. 2003, Vaseeharan and Ramasamy 2003, Cude, Mooney et al. 2012). When
probiotic bacteria pre-mixed in algae feed was used to treat shrimp ponds in a high
density, there were antagonistic properties exhibited against pathogenic Vibrio spp. in
the gut of the crustaceans to improve host survival (Decamp, Moriarty et al. 2008).
There are many probiotic bacteria that have been cited to be useful for the treatment of
bacterial disease in aquaculture (Rengpipat 1998, Rengpipat, Phianphak et al. 1998,
Gatesoupe 1999, Naik A.T.R. 1999, Riquelme, Jorquera et al. 2001, Meunpol,
Lopinyosiri et al. 2003, Farzanfar 2006, Vine, Leukes et al. 2006, Ziaei-Nejad, Rezaei
et al. 2006, Decamp, Moriarty et al. 2008, Romalde and Barja 2010). A study by
Meunpol et al. suggested that the probiotic Bacillus S11 was a contributing factor to
the survival of black tiger shrimp (Penaeus monodon) against bacterial pathogen V.
harveryi (Meunpol, Lopinyosiri et al. 2003). One of Bacillus’ mechanism of action is
the antagonistic effect of Bacillus against the pathogenic Vibrios sp. (Vaseeharan and
Ramasamy 2003). A study by Rengpipat et al. examined the growth of P. monodon
and its resistance to Vibrio when fed with Bacillus (BS11) (Rengpipat, Phianphak et
al. 1998). Their results suggest that the growth and survival rates of P. monodon fed
on the probiotic supplement were signiﬁcantly higher than the controls (Rengpipat,
Phianphak et al. 1998).
Although there has been much promise in the study of potential probiotics in
shellfish aquaculture, no commercial products are currently available for bivalve
larviculture. This is despite the fact that probiotic agents have been created for other
aquacultured species, including penaeids, catfish, water rotifers and tilapia (Hirata,
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Murata et al. 1998, Queiroz and Boyd 1998, Murthy and TJ 1999, Irianto and Austin
2002, Cutting 2011, Parthasarathy, Ramasubramanian et al. 2012). All of these
commercial probiotics are gram-positive bacteria, such as Bacillus sp.
Previous results by Karim et al. determined both Bacillus pumilus RI0695 and
Phaeobacter gallaeciensis S4 exhibited antagonistic effects towards Vibrio tubiashii
in vitro (Karim, Zhao et al. 2013). Additionally they were able to protect C. virginica
larvae when challenged with V. tubiashii in vivo (Karim, Zhao et al. 2013). Karim et
al. proposed the potential mechanisms of action for B. pumilus RI0695 and P.
gallaeciensis S4 could include excretion of an antibiotic molecule, biofilm formation
by the bacterium, immune modulation of the oyster larvae, and colonization of
marine surfaces play a role in its probiotic activity (Karim, Zhao et al. 2013). B.
pumilus RI0695 was previously found to produce the antibiotic amicoumacin (Socha
2008). In this study, we explore creating a granular formulation of B. pumilus RI0695
for delivery as a disease management tool in commercial shellfish larviculture
facilities. Granular formulations were tested for the viability of the bacteria over time
and at different storage temperatures, and were evaluated for their protection of
oyster larvae against bacterial pathogens.
Materials and methods
Bacterial Cultivation
B. pumilus RI0695 was isolated by the Rowley laboratory at URI (Socha
2008). R. crassostreae Cv 919-312T and V. tubiashii RE22 were provided by Dr.
Marta Gómez-Chiarri (University of Rhode Island), and Vibrio harveyi BB120 was
provided by Dr. David Nelson (University of Rhode Island). All bacteria were
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cultured in a seawater-based yeast extract-peptone culture medium (YP; 5 g/L of
peptone, 1 g/L of yeast extract, and 30 g/L of Instant Ocean (Blacksburg, VA) in pure,
reverse osmosis (RO) water) at 28 °C and shaking at 175 rpm. V. harveyi and R.
crassostreae were used for in vitro antibiotic susceptibility testing, while V. tubiashii
was used for larval oyster challenges. Bacterial stocks were stored at −80 °C in YP
broth with 25% glycerol until use.
Formulation of Bacterial Cells
Four 1L cultures of RI0695 were incubated at 28 °C and shaking for 96 hours.
The cells in the cultures were harvested by centrifugation at 18,600 x g for 10 min at
20 °C. The supernatant was decanted, and the cell pellet was then resuspended in 150
mL of sterile artificial seawater and re-pelleted. The resulting bacterial cell pellet was
then either (1) dried to a ‘damp mass’ at 30 °C for 12 h in a convection oven with
continuous airflow, or (2) dried at 22 °C for 48 h. The dried cell pellets were extruded
through three different-sized USA standard sieve stainless steel screens (Cole Palmer,
Illinois, USA): 40 mesh, 80 mesh, and 325 mesh. The 40 mesh, 80 mesh, and 325
mesh screens yield average size particle sizes of 420 µ, 177 µ and 43 µ, respectively.
Each formulated product was stored in glass vials at either room temperature
(approximately 25 °C) or 4 °C.

Colony-Forming Unit (CFU) Viability Assay
The cell viability of all formulated probiotics was determined at 1, 2, 5, 8 and
12 weeks after formulation. Formulated products were prepared at a 5 mg/mL
concentration in sterile artificial seawater, allowed to dissolve standing for 10 min,
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and vortexed for 1 min. Dilutions of 1:10 and 1:100 of the stock (5 mg/mL) in sterile
artificial seawater were prepared in triplicate. 10 µL of each dilution was spread onto
YP agar plates in triplicate. The YP plates were incubated for 48 h at 27 °C and then
colonies were counted. Each assay was performed in duplicate.

Antibiotic activity of the formulations against bacterial pathogens
Bacteria from each formulation were cultivated on agar plates and assessed for
their ability to inhibit the growth of R. crassostreae and V. harveyi BB120 (Karim,
Zhao et al. 2013). Overnight cultures of either R. crassostreae or V. harveyi BB120
were spread onto YP agar plates. Each of the formulated products (5 mg/mL in sterile
artificial seawater) and an overnight culture of RI0695 (control) were pipetted (10 µL)
in triplicate onto each YP plate. Each plate was incubated for two days at 27 °C and
then assessed for zones of growth inhibition surrounding the colonies of RI0695.
Assays were performed in triplicate.

Characterization of cell morphology of granular products
The cell morphology of the granular formulations (420 µ, 177 µ and 43 µ) was
examined by phase contrast microscopy (Zeiss Axio Imager 2 microscope using
phase-contrast optics, 100x magnification). Three aliquots of 104 CFU/mL dilutions in
sterile artificial seawater (28psu) were prepared for each formulation from their
rehydrated 5 mg/mL stock solutions. A 48 h, 10 mL fresh culture of the probiotic
candidate RI0695 bacteria was examined as the control.
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Oyster challenge assays
Oyster Larvae
Eastern oyster (C. virginica) larvae (10 – 15 days old) were obtained from the
Blount Shellfish Hatchery at Roger Williams University, Bristol, RI. The larvae were
divided into six wells containing 5 mL of aerated filtered sterile seawater (FSSW, 28
psu) and allowed to acclimate at room temperature (approx. 20 °C) for 24 hours before
treatment. The larvae were fed commercial algal paste (Reed Mariculture Inc., San
Jose, CA. USA) daily during the experiments. The water in each well was changed
with FSSW every 48 hours.
Probiotic treatments of oyster larvae and challenge experiments
The ability of the RI06-95 formulations to protect larvae to challenge with the
pathogen V. tubiashii was tested following established protocols (Karim et al. 2013).
These experiments were run in triplicate. Treatments (each performed in duplicate)
included: no probiotic treatment and no challenge; no probiotic treatment and
challenge; probiotic treatments (either the 43 µ or the 177 µ formulation) and no
challenge; and each of the probiotic treatments and challenge. Probiotics (fresh or
formulations) were added to the larvae at a concentration of 104 CFU/mL with the
algal food and incubated at room temperature for 24 h. Larvae were then removed
from each well and filtered through a nylon mesh (75 µ). Larvae retained on the mesh
were resuspended in 5 ml of FSSW, and placed back in the original wells. Larvae
were then challenged with V. tubiashii (105 CFU/mL). Larval survival was monitored
at 24 h after challenge by staining with neutral red (200 µL). The relative percent
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survival compared to the challenged control (no probiotic treatment) was calculated
using the following formula:
%survival challenged control oysters

Relative Percent Survival = [1- (%survival challenged treatment oysters)] x100
Probiotic treatments of oyster juveniles and challenge experiments
A total of 261 all ages Eastern oyster triploid juveniles (1.36+0.32 mm x1,
32+0.40 mm) were obtained from Blount Shellfish Hatchery at Roger Williams
University, Bristol, RI.. The oyster juveniles were divided into six 1 L containers
containing 700 mL of FSSW as follows: one control (no probiotic, no challenge), one
challenge control (no probiotic, challenged), two containers treated with the 43 µ
RI0695 granules before challenge, and two containers treated with the 177 µ RI0695
granules before challenge. Juvenile oysters were maintained in aerated FSSW at room
temperature for 24 h prior to any treatment. Oysters were fed commercial algal paste
(Reed Mariculture) throughout the experiment and the water was exchanged changed
with fresh FSSW every 48 h. Probiotics (104 CFU/mL) were added to the larvae daily
with food or 7 days. On day 2 after the start of the treatment, oysters were challenged
with V. tubiashii (105 CFU/mL) after a water exchange. Juvenile oysters were assessed
for viability using a dissecting microscope over the 9 d period. Percent survival and
relative percent survival relative to the non-treated challenge control was calculated as
described above. These experiments were run in duplicate.
Statistical analysis
The challenge data set survival counts data was analyzed by one way
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(ANOVA) followed by Tukey’s Test was used to determine significant level between
groups. Data colleged as a percentage were arsine of the square root-transformed
before analysis. Results were considered significant at the 95% level of confidence
(p<0.05). Statistics were run using Sigmastat 3.1 software (Systat).The cell viability
data granular size and biological replicates were analyzed by two way (ANOVA)
followed by Tukey’s Test for each temperature and each time point. Cell viability data
biological replicates were analyzed for both temperature conditions at each time point
using a one-way analysis of variance (ANOVA ) followed by Dunn’s method. All
statistical analysis were performed using Sigma stat 3.1 software (Systat). Differences
were considered to be significant at values of P < 0.05.
Results
Effect of granulation on cell viability
Liquid cultures of B. pumilus RI0695 cells were successfully formulated into
granules. In a representative experiment, 1L of a 96 h culture of RI06-95 provided a
total of 450.3 mg of 420 µ granules, 245.5 mg of 177 µ granules, and 155.1 mg of 43
µ granules.
The effect of the granulation processes on cell viability was assessed by
measuring live cells both prior to and after formulation (Table 1). Prior to formulation,
RI0695 cultures yielded at least 108 CFU/mL. The cell viability of the formulated
granules was assessed over 8 weeks using by measuring CFU per mg over time
(Tables 1-3). In general, the granulation process consistently delivered products that
contained between 5 x 105 and 5 x 106 CFU/mg, and the viability of the formulated
products remained relatively stable over an 8 week period, regardless of storage
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temperature (p>0.05). Interestingly, granules stored at room temperature were
significantly different. There were often demonstrated increases in CFU/mg over time,
perhaps due to some humidity in the particles following the formulation step causing
inaccurate weight of samples and inaccurate cell viability (Figures 1-6).
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Figure 1. Cell Viability vs. Time of 420 µ granules stored at 4 °C. Each experiment was performed in triplicate.
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Figure 2. Cell Viability vs. Time of 420 µ granules stored at room temperature (RT). Each experiment was performed
in triplicate.

Table 1. Cell viability of B. pumilus RI0695 in 420 µ granules (Log(CFU/mg)) over 8 weeks while stored at either room
temperature (RT) or 4 °C.

Exp. 1 (RT)

Exp. 2 (RT)

Exp. 3 (RT)

Exp. 1 (4 °C)

Exp. 2 (4 °C)

1

5.93+ 0.05 b

5.85+0.03 b

6.00+ 0.02 b

6.34+0.05 b

5.86+0.05 b

2

6.44+0.04 a b

6.44+ 0.35 a b

6.51+ 0.03 a b

5.92+0.35

5.48+0.35

5

5.87+0.14 b

5.87+ 0.05 b

6.35+ 0.20 b

6.17+0.07 b

6.17+0.07 b

8

6.35+ 0.34 a b

6.35+0.39 a b

6.47+ 0.12 b

5.87+0.05

5.76+0.05

92

Time (Week)

a

1 way ANOVA analysis indicates bioreplicate experiments were significantly different.

b

2 way ANOVA analysis indicates that results with 420 µ granule formulation was significantly different from

results with the other granule sizes.
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Figure 3. Cell Viability vs. Time of 177 µ granules stored at 4 °C. Each experiment was performed in triplicate.
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Figure 4. Cell Viability vs. Time of 177 µ granules stored at RT. Each experiment was performed in triplicate.

Table 2. Viability of B. pumilus RI0695 177 µ granules (Log(CFU/mg)) over 8 weeks while stored at RT and 4 °C

Time (Week)

Exp. 1 (RT)

Exp. 2 (RT)

Exp. 3 (RT)

Exp. 1 (4 °C)

Exp. 2 (4 °C)

1

5.78+ 0.09 b

5.78+ 0.07 b

5.78+ 0.05 b

5.87+ 0.17 b

5.80+0.17 b

2

6.61 + 0.07 a b

6.61+ 0.90 a b

5.78+ 0.08 a b

5.75+0.11

5.83+0.11

5.87+0.13

5.62+0.13

5.76+0.13 a b

5.11+0.13 a b

b

5

6.50+ 0.11

8

5.37+ 0.1 b 2

6.50+ 0.80

b

5.37+ 0.17 b

5.87+ 0.30

b

6.47+ 0.16 b
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a

1 way ANOVA analysis indicates bioreplicate experiment was significantly different.

b

2 way ANOVA analysis indicates that results with 177 µ granule formulation was significantly different from

results with the other granule sizes.
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Figure 5 Cell Viability vs. Time of 43 µ granules stored at 4 °C. Each experiment was performed in triplicate.
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Figure 6. Cell Viability vs. Time of 43 µ granules stored at RT. Each experiment was performed in triplicate.

Table 3. Cell viability of B. pumilus RI0695 43 µ granules (Log(CFU/mg)) over 8 weeks while stored at RT
and 4 °C

Time (Week)
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Exp. 1 (RT)

Exp. 2 (RT)

1

5.57+ 0.10

5.26+ 0.13

2

6.64+ 0.10 a b

5
8

Exp. 3 (RT)

Exp. 1 (4 °C)

Exp. 2 (4 °C)

5.86+ 0.5

5.57+0.10

5.89+0.03

6.61+ 0.09 a b

5.78+ 0.07 a b

5.72+0.09 b

5.72+0.09 b

5.48+ 0.23 a b

6.50+ 0.23 a b

5.41 + 0.30 a b

5.41+0.30 a

5.48+0.23 a

5.62+ 0.28 a b

5.37+ 0.14 a b

6.31+ 0.16 b a

5.62+0.28 a b

5.65+0.19 a b

a

1 way ANOVA analysis indicates bioreplicate experiment was significantly different.

b

2 way ANOVA analysis indicates that results with 43 µ granule formulation was significantly different from

results with the other granule sizes.

Effect of granulation on antimicrobial activity and cell morphology
Since antibiotic production by B. pumilus RI0695 may be critical to the desired
probiotic activity (Socha 2008), the colonies derived from the formulated products
were tested for their ability to limit the growth of V. harveyi BB120. There were
comparable zones of no growth surrounding all the B. pumilus colonies, demonstrating
that the formulation process had no effect on antibiotic production during subsequent
cultivations (Table 4).

Table 4. Spot overlay in vitro assay of the all B. pumilus RI0695 particle sizes

Granulation

Zone of Inhibition
7 mm

420 µ

8 mm

177 µ

8 mm

43 µ
Control

8 mm

1000 µL of a 5 mg/mL solution of each granule size (420 µ, 177 µ and 43 µ) was inoculated in YP broth for
48 h at 27 °C with shaking at 175 rpm. B. pumilus RI0695 from cryostocks served as the control.

Effect of granulation on cell morphology
The resuspended RI0695 formulations all retained the same morphology as the
RI0695 grown from cryostock. Each of the resuspended granulated formulations
exhibited individual small rods and spores that are consistent with the bacterium B.
pumilus RI0695 (Figure 7).
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(a)

(b)

(d)

(c)

Figure 7. (a) Cell morphology of 420 µ granules resuspended in seawater to
105CFU/mL and examined at 100 x magnification (b) Cell morphology of 177 µ
granules resuspended in seawater to 105 CFU/mL and examined at 100 x
magnification (c) Cell morphology of 43 µ formulation resuspended in seawater to 105
CFU/mL and examined at 100 x magnification (d) Cell morphology of B. pumilus
RI0695 (grown from cryostocks)

Oyster larval challenges
The granular formulations were next tested for probiotic activity using in vivo
oyster larval and juvenile bacterial challenge assays. Two of the particle size
formulations (177 µ and 43 µ) were chosen because the oyster larvae and seed in the
hatcheries range from approximately 40-200 µ in size. The smaller particles that are
easily soluble in water were considered as better candidates for hatchery delivery since
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they might not cause sinking of swimming larvae (Karen Tammi, Blount Shellfish
hatchery, personal communication). Each formulation was 29 weeks old at the time
of the experiment. Cell viabilities of the 177 µ and 43 µ formulations were found to
be 5.31 + 4.93 log (CFU/mg) and 5.90 + 5.21 log (CFU/mg), respectively, and each
was added to treated oysters at 104 CFU/mL. Neither of the formulations was found to
be detrimental to oyster survival (Figure 8). Survival of the oyster larvae after 24 h
exposure to pathogen V. tubiashii RE22 was reduced to 25+5%. Oyster larvae
pretreated with the 177 µ and 43 µ RI0695 formulations at 104 CFU/mL and then
exposed to V. tubiashii demonstrated greater survival rates than larvae exposed to
pathogen alone. The level of protection was similar between formulations (Table 5).
The formulations provided larval protection similar to what was previously seen with
probiotic treatments of freshly cultured B. pumilus RI0695 (104 CFU/mL) (Karim,
Zhao et al. 2013).
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Effect of RI0695 granules challenged with Vibrio tubiashii
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Figure 8. Effect of preincubation of oyster larvae with RI0695 granules (177µ and 43µ) at 10 4 CFU/mg on survival % (+SE)
24 hours after challenge with V. tubiashii RE22. Representative of 3 experiments.

Table 5. Effect of pre-incubation with 177 µ and 43 µ RI0695 granules on survival (%
survival) of oyster larvae and seed after challenge with bacterial pathogen Vibrio
tubiashii RE22.

RE22 only (105
CFU/mL)

Pretreated with
probiotic formulation
(104 CFU/mL)
43 µ

177 µ

Oyster
Larvae

25+5

84+3

83+5

Oyster Seed

53+13

86+14

100+0

Control fresh
Bacillus pumilus
RI0695 (104
CFU/mL)
NA

85+8

Oyster seed challenges

The 177 µ and 43 µ formulations were next tested for protection of oyster seed against
V. tubiashii infection. After 7 days, RI0695 granules were harmless to the seed with
survival rates (SR) of 100+ 0% and 86+14%, respectively, for the 177 µ and 43 µ
formulations (Figure 9 and table 5). The protection provided by the 177 µ and 43 µ
granules to both oyster larvae and seed was similar to that provided by freshly cultured
B. pumilus RI0695.
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Oyster Survival (%)

Effect of Granules on Oyster Seed Challenged with V. tubaishii
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Figure 9. Effect of preincubation on oyster seed with freshly cultured B. pumilus (RIO695) and formulated granules (177µ and
43µ) at 104 CFU/mL. Controls included seed oysters exposed to no additional bacteria (Control) and oysters exposed to only
V. tubiashii (RE22). In the challenge experiments, the seed oysters were pretreated with the B. pumilus 24 hours prior to
addition of the V. tubiashii RE22. Representative of 1 experiment.

Discussion

Previous results by Karim and coworkers determined both Bacillus pumilus
RI0695 and P. gallaeciensis S4 exhibited antagonistic effects towards V. tubiashii in
vitro (Karim, Zhao et al. 2013). More importantly, they were able to protect C.
virginica larvae when challenged with V. tubiashii in vivo (Karim 2013, Karim, Zhao
et al. 2013). However, this study measured the probiotic effects of freshly cultured
bacteria, an approach that is not feasible at commercial shellfish hatcheries. Granular
formulation was chosen for this study because it is a cost effective process. One
parameter we sought to measure was cell viability over time. A probiotic formulation
might be stored at a hatchery for weeks or months before use, so a successful product
must be stable. While the formulations generally appeared to be stable at both
temperatures tested, measuring the cell viability of the granular formulations proved
to be difficult. There was variability in cell viability in all of the granule sizes
formulated based on the log(CFU/mg) data at each time point (1-8 weeks). A large
variation in cell viability in the 420 µ granules may be caused by several reasons.
First, the granules might not have fully redissolved into seawater, thus causing some
heterogeneity in the samples used to determine viable cell counts. Second, the 420 µ
granules appear to have had some increases in numbers of viable cells by the second
week of storage at room temperature, suggesting that the particles may have absorbed
water effecting the weight of the sample. This could cause variations in the cell
viability counts. Third, the formulations were tested at different times of the year and
thus may have been influenced by changes in humidity. More humid storage
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conditions could affect particle clumping and thus size and dissolution. Our results
suggest that storage of the granules could be at either 4 °C or RT (~25 °C) since the
products were relatively stable at each temperature. However, storage at 4 °C was
less variable in cell viability because the relative humidity is more controlled, and
therefore might be optimal for hatcheries that experience large ambient temperature
fluctuations in the summer.
Based on the cell viability studies of granules up to 8 weeks, the cell
viabilities per milligram of granules are in a range sufficient to provide probiotic
effects against V. tubiashii infection. A probiotic formulation should have shelf-life
of at least 12 weeks, since the normal spawning season of wild oysters is June
through August (UMCES 2014). The granular formulations satisfy this requirement
since both the oyster seed and larval challenges were performed with formulations
that were greater than 20 weeks old and yielded similar relative percent survival
compared to the freshly cultured B. pumilus RI0695 control. Bacteria cultured from
the granules retained both antibiotic activity and cell morphology identical to cell
cultured from frozen stocks.
Future studies should be directed at measuring the time it takes the dried
granules to fully disintegrate. Knowing the conditions to get complete dissolution of
the particles would enable more consistent cell viability counts for the formulations.
Other potential probiotic formulations could be also explored, such as a lyophilized
product or a liquid formulation for ease during scale up for commercial production.
However, the granular formulations prepared here provided cell viabilities above 105
CFU/mg (log(CFU/mg) = 5.0), suggesting that sufficient bacteria remained viable for
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use in treating aquaculture tanks. For example, tanks that are 100 L would require
least 10.0 g per treatment. Future pilot studies in commercial hatcheries are now
needed to test the suitability of these products for commercial use.
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Abstract
Probiotic agents have the potential to mitigate disease outbreaks in aquaculture
facilities. However, there are currently no commercially available probiotics for
shellfish larviculture. The marine bacterium Phaeobacter gallaeciensis S4 was
previously reported to provide significant protection of Eastern oyster, Crassostreae
virginica, larvae against the shellfish pathogen Vibrio tubiashii. This investigation
aimed to create a stable, lyophilized formulation of P. gallaeciensis S4 for potential
delivery at shellfish hatcheries. Lyophilized formulations of P. gallaeciensis S4 were
prepared at both log and stationary growth phases, and two cryoprotectants, sucrose
and mannitol, were investigated. For each cyroprotectant, three weight by volume
concentrations were tested: 20% (w/v), 30% (w/v) and 40 % (w/v). The formulated
bacteria were stored at various temperatures, including 4 °C, room temperature (RT),
30 °C, and 30 °C with 75 % humidity. The best results were achieved with the 30-M
(30% mannitol) formulation stored at RT. This formulation provided cell viabilities of
4.39+3.69 log(CFU/mg) after 1 week of storage, but lost an additional 30% of the
viable cells over the following 1 week. Since a goal of the study was to prepare a
formulation that exceeded 105 CFU/mg and remained relatively stable for at least 12
weeks, none of the formulations were considered a success.

Introduction
To reduce the threat of disease, hatcheries employ various strategies to
eliminate pathogens, including seawater filtration systems, ozonolysis and UV
treatments of seawater, controlling salinity, selective breeding of the cultured species,
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and electrolytic treatments of incoming seawater (Ruiz-Ponte, Samain et al. 1999,
Jorquera, Valencia et al. 2002, Meunpol, Lopinyosiri et al. 2003, Park, Kim et al.
2011). Despite these approaches, infectious diseases continue to be problematic for
shellfish hatcheries. The use of probiotic bacteria is an attractive alternative to
disease management in bivalve hatcheries, but no commercial probiotic products
currently exist for this area of aquaculture.
Probiotic bacteria are defined by the World Health Organization as live
microorganisms that provide a beneficial effect to the host (FAO 2002).
Investigations to identify potential probionts for bivalve aquaculture have shown
promise. Ruiz-Point et al determined that Roseobacter strain BS 107 was able to
improve the survival of Pecten maximus when challenged by Vibrio anguillarum 408
(Ruiz-Ponte, Samain et al. 1999). Gibson et al. demonstrated that probiotic candidate
Aeromonas media sp. 199 produced an inhibitory substance that contributed to the
antagonistic effects in vitro as well in vivo towards V. tubiashii (Gibson, Woodworth
et al. 1998). Riquelme et al. demonstrated Anthrobacter strain 77 exuded compounds
that inhibited Vibrio esplendidus, Vibrio alginolyticus and Aeromonas hidrophyla.
Riquelme additionally determined Anthrobacter strain 77, when ingested, was able to
colonize the gut was not toxic to Chilean scallop larvae. (Riquelme, Jorquera et al.
2001). Vibrio strain OY15, a naturally-occurring bacterium present in the digestive
glands of adult C. virginica, increased survival of oyster larvae when challenged with
pathogen Vibrio sp. strain B 183 (Kapareiko, Lim et al. 2011). Karim et al. showed
that P. gallaeciensis S4 and Bacillus pumilus RI0695 exhibited protective effects of
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Crassostrea virginica larvae when challenged with V. tubiashii both in vitro and in
vivo (Karim, Zhao et al. 2013).
Delivery of freshly cultured bacteria is not a feasible approach for disease
management at commercial shellfish hatcheries. Lyophilization as a means to create a
stable formulation was chosen for this study because of previously demonstrated long
shelf life of stored lyophilized microbes (Leslie, Israeli et al. 1995, Costa, Usall et al.
2000, Miyamoto-Shinohara, Imaizumi et al. 2000, Hubálek 2003, MiyamotoShinohara, Sukenobe et al. 2006, Savini, Cecchini et al. 2010). Miyamoto-Shinohara
et al. observed that gram negative bacteria containing polar flagella had low to
moderate (58.2+25.0 % to 10.7%) cell viability survival rate post lyophilization
(Miyamoto-Shinohara, Sukenobe et al. 2008). Sucrose, mannitol and trehalose have
been previously chosen when formulating gram negative bacteria for their
extracellular cryoprotection (Leslie, Israeli et al. 1995, Costa, Usall et al. 2000,
Miyamoto-Shinohara, Imaizumi et al. 2000, Hubálek 2003, Miyamoto-Shinohara,
Sukenobe et al. 2006, Miyamoto-Shinohara, Sukenobe et al. 2008, Savini, Cecchini et
al. 2010). Mannitol and sucrose were chosen for this study due to their ability to
protect the cell membrane of Gram negative bacteria (Costa, Usall et al. 2000,
Hubálek 2003, Savini, Cecchini et al. 2010).
An important next step in the development of probiotic bacteria for shellfish
aquaculture is the creation of stable and safe formulations. Freeze drying is a
commonly used method in microbial culture storage (Leslie, Israeli et al. 1995, Costa,
Usall et al. 2000, Miyamoto-Shinohara, Imaizumi et al. 2000, Hubálek 2003,
Miyamoto-Shinohara, Sukenobe et al. 2006, Miyamoto-Shinohara, Sukenobe et al.
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2008, Savini, Cecchini et al. 2010). In this study, we explored lyophilized
preparations of P. gallaeciensis S4 for their cell viability over time and protection of
oyster larvae against V. tubiashii infections.

Methods and Materials
Bacterial cultivation
P. gallaeciensis S4, R. crassostreae Cv 919-312T (Boettcher, Geaghan et al.
2005) and V. tubiashii RE22 (Elston, Hasegawa et al. 2008) were provided by Dr.
Marta Gómez-Chiarri (University of Rhode Island). Vibrio harveyi BB120 was
provided by Dr. David Nelson (University of Rhode Island). All bacteria were
cultured in a seawater-based yeast extract-peptone culture medium (YP). YP media
was prepared using 5 g/L of peptone, 1 g/L of yeast extract, and 30 g/L of Instant
Ocean (Blacksburg, VA) in pure, reverse osmosis (RO) water. For YP agar, 15 g of
agar per L. R. crassostreae were used for in vitro antibiotic susceptibility testing,
while V. tubiashii was used for challenges. P. gallaeciensis S4 was cultured at 28 °C
and shaking at 175 rpm. Bacterial stocks were stored at −80 °C in YP broth with 25%
glycerol until use.
Formulation of Bacterial Cells
Forty-eight 50 mL cultures of S4 were incubated at 28 °C for 48 hours.
Bacteria growth was measured by measuring the absorbance (OD600). The cultures
were formulated at two time points: (1) OD600= 0.5+0.1 or ~105 CFU/mL, and (2)
OD600=0.8 or ~108 CFU/mL (personal communication with Dr. Wenjing Zhao). Time
point (1) was considered to be exponential growth phase and time point (2) was
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considered to be stationary growth phase (personal communication with Dr. Wenjing
Zhao). The cells were harvested by centrifugation at 4,500 x g for 10 min at 20 °C.
The cell pellet was then washed in 5 mL of sterile artificial seawater twice. The
resulting bacterial cell pellet was re-suspended in 5 mL of artificial seawater and either
(1) 20%, 30% or 40% (w/v) of mannitol (20-M, 30-M, 40-M) or (2) 20%, 30% or 40%
(w/v) of sucrose (20-S, 30-S 40-S). Each formulation was given a designation: LGP
denotes formulation during exponential growth phase while SGP designates a
formulation from S4 in the stationary growth phase (e.g. 30-M SGP). All
formulations were thoroughly mixed, frozen at -80 °C overnight, and then lyophilized.
A sterilized spatula was used to break up the lyophilized presscake into a free-flowing
powder. The formulated products were stored in plastic centrifuge tubes at either
room temperature (RT) (approximately 22+3 °C), 4 °C for 5 weeks, 30 °C for 4
weeks, or 30 °C with 75% relative humidity for 4 weeks.
Colony-Forming Unit (CFU) Viability Assay
The cell viability of probiotic formulations stored at RT and 4 °C was
determined at 1, 2, and 5 weeks. Cell viability assay was performed at 2 and 4 weeks
for formulations stored at 30 °C and 30 °C with 75% relative humidity. All
formulations were reconstituted in 5 mL of sterile reversed osmosis water to a
concentration of 200, 300 or 400 mg/mL of 20-M LGP, 30-M LGP and 40-M LGP.
1:10 and 1:100 dilutions ranging from 102-107 CFU/mL were created from the 5 mL
stock of formulations in YP broth in triplicate. 10 µL of each dilution was pipetted
onto YP agar plates in triplicate. The YP plates were incubated for 48 h at 27 °C and
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then colonies were counted. The assay for each formulation was performed in
duplicate.
Antibiotic activity of formulated P. gallaeciensis S4 against bacterial pathogens
S4 from each formulation was tested for growth inhibitory activity against R.
crassostreae (Karim, Zhao et al. 2013). An overnight culture of R. crassostreae was
diluted to approximately 108 CFU/mL in YP media. The diluted bacterium was
swabbed onto an YP agar plates. Overnight culture of formulated products (10 µL of 5
mL stock) in YP media and an overnight culture of P. gallaeciensis S4 from cryostock
(control) were pipetted (10 µL) in triplicate on each YP plate. Each plate was
incubated for 48 h at 28 °C. Zones of growth inhibition surrounding the colonies of S4
were measured to the nearest mm. Assays were performed in triplicate.
Characterization of cell morphology of lyophilized products
The cell morphology of the 30-M LGP and 40-M LGP and stationary
formulations were examined by phase contrast microscopy magnified at 100x (Zeiss
Axio Imager 2 microscope). Three 102 CFU/mL dilutions in YP media were prepared
for each formulation from their rehydrated 5 mL stock solutions.
Oysters challenge assays
Oyster larvae
10-day old oyster larvae (C. virginica) were obtained from Blount Shellfish
Hatchery at Roger Williams University, Bristol, RI. The larvae were divided into six
wells containing 5 mL of aerated sterile seawater (FSSW) and allowed to settle at 20
°C for 24 h. The larvae were fed algal paste (Reed Mariculture Inc., San Jose, CA.
USA daily. The water in each well was changed with FSSW every 48 h.
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Probiotic treatments of Oyster Larvae
The experiment consisted of six wells containing larvae with various
treatments: a positive control group (no treatment), a negative control group treated
with V. tubiashii, two 30-M LGP treatment groups and two 40-M LGP treatment
groups. The positive control groups contained 147 + 40 larvae and were fed
commercial algal paste (Reed Mariculture Inc., San Jose, CA. USA) daily only. The
negative control group contained 95 + 52 larvae and were fed commercial feed and
treated with V. tubiashii (105 CFU/mL) after 24 h. Two wells containing 79 + 20
larvae were treated with 30-M LGP (104 CFU/mL) and two wells containing 70+30
larvae were treated with 40-M LGP (104 CFU/mL). All treatments were performed in
triplicate.
Oyster Larvae Challenge
After 24 h, one well treated with1 week old 30-M LGP and one well treated
with the 1 week old 40-M LGP were washed and challenged with V. tubiashii (105
CFU/mL). The negative control well was treated with V. tubiashii (105 CFU/mL).
After an additional 24 h, all wells were stained with neutral red (200 µL) and live
larvae were counted. These experiments were run in triplicate. The relative percent
survival was calculated using the following formula:
% survival challenged control

Relative Percent Survival = [1-

%survival treatment

] x 100

Statistical analysis
The challenge data were analyzed by one-way analysis of variance (ANOVA
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). This data were analyzed using Sigma stat 3.1 software (Systat). Differences were
considered to be significant at values of P < 0.05.
Results
Effect of cryoprotectant on lyophilization process

After the lyophilization process, all sucrose lyophilized formulations were a
solid crystallized mass. In contrast, all mannitol lyophilized products were
homogenized into a loose-flowing powder.

Effect of lyophilization on antimicrobial activity
All of colonies arising from the S4 stationary growth phase (SGP) lyophilized
powders and the 20-M LGP powder did not produce zones of growth inhibition
against R. crassostreae. These colonies were white in appearance, which is different
compared to the yellow color normally observed with S4 cultures from cryostock
(Figure 3). The 30-M LGP and 40-M LGP formulations had comparable zones of no
growth surrounding all the S4 colonies, similar to the area of no growth surrounding
the freshly cultured S4 (Table 1).
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Table 1. Antibiotic activity of formulated P. gallaeciensis S4 versus R. crassostreae.

Lyophilization

Clear Zone of inhibition

20-M log phase

0 mm

30-M log phase

8 mm

40-M log phase

8 mm

20-M stationary phase

0 mm

30-M stationary phase

0 mm

40-M stationary phase

0 mm

Control (P. gallaeciensis S4)

10 mm

10 µL of a 5 mL solution of all lyophilized mannitol (M) formulations was grown in YP broth for 48 h
at 27 ° C shaking 175 rpm. Control was P. gallaeciensis S4 from cryopreserved stock. 10 µL of the
resulting cultures were spotted onto plates inoculated with R. crassostreae and incubated at 27 ° C for
24 hours. The diameters of zones of no growth surrounding S4 colonies were measured to the nearest
mm.

Impacts of lyophilization on P. gallaeciensis S4
The cell viability of the 30-M LGP and 40-M LPG stored at RT and 4 °C was
assessed over 5 weeks using by measuring CFU per mg over time. Unfortunately
neither formulation produced any viable cells (Table 2 and Table 3). The effect of the
lyophilization processes of formulated products retaining antimicrobial activity (30-M
LGP and 40-M LPG) were assessed by measuring the cell viability prior to and after
formulation. Storage of 30-M LGP and 40-M LGP at 30 °C, both with 75% relative
humidity and without humidity, did not produce any viable cells at the first assessment
of CFU/mg at 2 weeks. The cell viability of the 30-M LGP and 40-M LPG stored at
RT and 4 °C had decreased 2 orders of magnitude post formulation. Additionally the
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viability rapidly decreased over 2 weeks. By 5 weeks there were no viable cells when
test formulations were assessed by measuring CFU per mg over time. (Table 2 and
Table 3).

Table 2. Cell viability of P. gallaeciensis S4 30-M log phase lyophilized formulation
(CFU/mg) over 2 weeks while stored at RT and 4 °C
Time

Exp. 1, RT

Exp. 2, RT

Exp. 1, 4 °C

Exp. 2, 4 °C

(CFU/mg)
1

4.39+3.69

4.22+3.37

3.51+2.31

3.43+2.37

2

3.26+2.25

3.18+2.18

3.69+2.11

2.98+1.91

5

0

0

0

0

Table 3. Cell viability of P. gallaeciensis S4 40-M log phase lyophilized formulation
(CFU/mg) over 2 weeks while stored at RT and 4 °C
Time

Exp. 1 RT

Exp. 2 RT

Exp. 1 4 °C

Exp. 2 4 °C

1

3.90+3.37

4.12+3.21

3.56+2.43

3.54+2.15

2

3.82+2.97

4.18+3.70

2.72+1.97

3.44+1.87

5

0

0

0

0
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Impacts of lyophilization on cell morphology
The 30-M and 40-M LPG, resuspended in 5 mL of DI water and diluted in YP
media, appeared as small ovoid cells under phase contrast at 100x (Figure 1), while
the 30-M and 40-M SPG had the formation of rosettes. Observed cell morphology
from both the LPG and SPG formulations were consistent with P. gallaeciensis S4
bacterium previously reported by Karim and coworkers (Karim, Zhao et al. 2013).
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a

b

c

d

Figure 1. (a) Cell morphology of 30-M SGP formulation using 100 x magnification; (b) Cell morphology of 40-M SGP
formulation using 100 x magnification; (c) Cell morphology of 30-M LGP formulation using 100 x magnification; (d) Cell
morphology of 40-M LGP formulation using 100 x magnification.
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Oyster larvae challenges
Cell viabilities of the 30-M LPG and 40-LPG were found to be 4.40 + 3.70 log
(CFU/mg) and 4.11 + 3.20 log (CFU/mg), respectively, and each was added to treated
oysters at 104 CFU/mL. Neither of the formulations were found to be detrimental to
oyster survival (Figure 5). Survival of the oyster larvae after 24 h exposure to
pathogen V. tubiashii RE22 was reduced to 25+5%. Oyster larvae pretreated with the
30-M LPG and 40-M LPG at 104 CFU/mL and then exposed to V. tubiashii
demonstrated the similar survival rates of 47+9% and 34+1%, respectively compared
to oysters treated with V. tubiashii alone and to each other (Figure 2). Both 30-M LPG
and 40-M LPG provided no protection of the oyster larvae. This was significantly
different than what was previously seen with probiotic treatments of freshly cultured
P. gallaeciensis S4 bacterium (104 CFU/mL) (Karim, Zhao et al. 2013).
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Figure 2. Protection effect of 30-M LGP and 40-LGP lyophilized formulation when challenged with V. tubiashii RE22
Oyster larvae was pretreated with rehydrated 30-M LGP and 40-M LGP diluted to 104 CFU/mL 24 hours prior to being challenged with V.
tubiashii RE22. Protection of oyster larvae was measured by percent survival (+standard error). Representative of 3 experiments.

Discussion
Phaeobacter have previously shown promise as probiotic agents for
aquaculture. Previous studies have reported several Roseobacter isolates that exhibit
antagonistic effects against pathogenic Vibrio species that are problematic in cod and
turbot larviculture(Brinkhoff, Bach et al. 2004, Bruhn, Nielsen et al. 2005, Porsby,
Nielsen et al. 2008, Porsby, Webber et al. 2011, D'Alvise, Lillebo et al. 2012).
Roseobacter isolates have been shown to produce tropodithetic acid, an antibiotic with
potent effects against marine and human pathogens (Kintaka, Ono et al. 1984,
Kawano, Nakagomi Kazuya. et al. 1998, Liang 2003, Porsby, Webber et al. 2011).
Karim and co-workers demonstrated that pre-treatment with fresh culture of P.
gallaeciensis S4 provided protection to oyster larvae when challenged with V.
tubiashii RE22.
A successful P. gallaeciensis S4 probiotic formulation for potential
commercial hatchery use should have cell viability above that required for a probiotic
effect. 104 CFU/mL was previously determined to be effective using freshly cultured
P. gallaeciensis S4 bacterium. Furthermore, the formulation should be stable for at
least 12 weeks since this the normal spawning season of both wild and aquacultured
oysters is June through August (UMCES 2014). Also, the formulation should
provide an antagonistic effect towards the pathogen V. tubiashii RE22 in vivo.
Unfortunately formulating S4 bacterium through lyophilization has proven to
be difficult. Lyophilized powders 30-M SGP and 40-M SGP had similar cell
morphology to freshly cultured P. gallaeciensis S4 bacterium when examined under
microscopy 100x. However, both formulations had lost antibiotic activity against R.
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crassostreae in vitro. While lyophilized powders 30-M LGP and 40-M LGP retained
antibiotic activity against R. crassostreae in vitro, reduced protection was observed in
the oyster larvae in the bacterial challenge with pathogen V. tubiashii RE22 (Karim,
Zhao et al. 2013). Also, the cell viability of both formulations rapidly decreased (2
weeks). By the 5th week, all formulations had no cell growth when tested. The cell
viability may have been adversely impacted by the freezing method or due to short
term exposure to the hyperosmotic environment created by the cryoprotectant.
The lyophilization of P. gallaeciensis S4 with two different cryoprotectants,
sucrose and mannitol, proved to be unsuccessful. It did not meet the criteria necessary
for a commercially available probiotic product. (30-M and 40-M) were not of
sufficient stability or viability (CFU >106) for use as a commercial probiotic product.
Log phase 30-M and 40-M formulations did not provide protection of C. virginica
larvae when challenged with V. tubiashii. Lyophilization of P. gallaeciensis S4 under
these conditions are not suitable for prevention of disease in oyster hatcheries. It may
be useful to examine if a cryoprotectant is necessary in creating a lyophilized P.
gallaeciensis S4 formulation. Slower freezing of the sample and less concentrated
cryoprotectants might also be beneficial. Other types of formulations should be
explored, such as liquid formulations using cells under starvation conditions.
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APPENDICES
Isolation scheme of TDA from P. gallaeciensis S4
Phaeobacter (S4) 7L
inoculated 4d, 27° 175 rpm

.

Acidified to pH=3 with FA
Subjected to liquid-liquid partition

Acidified ethyl acetate crude extract

Aqueous layer

Reversed phase (C18) medium
pressure combiflash chromatography
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Purified TDA (10mg)
Confirmed by

HPLC

ESI-TOF MS

IR

1

H NMR

IR Spectrum Thermo Nicolet 6700 FT-IR software Imic 8.1.11 (Thermo)
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One way ANOVA analysis for cell viability of 420 µ granules 1 w stored at 4° C
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One way ANOVA analysis for cell viability of 420 µ granules 2 w stored at 4° C
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One way ANOVA analysis for cell viability of 420 µ granules 5 w stored at 4° C
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One way ANOVA analysis for cell viability of 420 µ granules 8 w stored at 4° C

143

One way ANOVA analysis for cell viability of 177 µ granules 1 w stored at 4° C
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One way ANOVA analysis for cell viability of 177 µ granules 2 w stored at 4° C
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One way ANOVA analysis for cell viability of 177 µ granules 5 w stored at 4° C
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One way ANOVA analysis for cell viability of 177 µ granules 8 w stored at 4° C
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One way ANOVA analysis for cell viability of 43 µ granules 1 w stored at 4° C
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One way ANOVA analysis for cell viability of 43 µ granules 2 w stored at 4° C
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One way ANOVA analysis for cell viability of 43 µ granules 5 w stored at 4° C
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One way ANOVA analysis for cell viability of 43 µ granules 8 w stored at 4° C
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One way ANOVA analysis for cell viability of 420 µ granules 1 w stored at RT
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One way ANOVA analysis for cell viability of 420 µ granules 2 w stored at RT
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One way ANOVA analysis for cell viability of 420 µ granules 5 w stored at RT
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One way ANOVA analysis for cell viability of 420 µ granules 8 w stored at RT
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One way ANOVA analysis for cell viability of 177 µ granules 1 w stored at RT

156

One way ANOVA analysis for cell viability of 177 µ granules 2 w stored at RT
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One way ANOVA analysis for cell viability of 177 µ granules 5 w stored at RT
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One way ANOVA analysis for cell viability of 177 µ granules 8 w stored at RT

159

One way ANOVA analysis for cell viability of 43 µ granules 1 w stored at RT
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One way ANOVA analysis for cell viability of 43 µ granules 2 w stored at RT
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One way ANOVA analysis for cell viability of 43 µ granules 5 w stored at RT
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One way ANOVA analysis for cell viability of 43 µ granules 8 w stored at RT
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Two way ANOVA analysis for cell viability of granules 1 w stored at 4 °C
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Two way ANOVA analysis for cell viability of granules 2 w stored at 4 °C
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Two way ANOVA analysis for cell viability of granules 5 w stored at 4 °C
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Two way ANOVA analysis for cell viability of granules 8 w stored at 4 °C
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Two way ANOVA analysis for cell viability of 420 µ granules 1 w stored at RT

168

Two way ANOVA analysis for cell viability of 420 µ granules 2 w stored at RT
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Two way ANOVA analysis for cell viability of 420 µ granules 5 w stored at RT
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Two way ANOVA analysis for cell viability of 420 µ granules 8 w stored at RT
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